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ABSTRACT 
 The objectives of this work include: validation of yeast-based assays, 
investigation of protein-protein interactions in the regulatory role of an intrinsically 
disordered protein, Ultrabithorax (Ubx), and exploration of possible application of Ubx 
self-assemble protein materials for cell culture study.  
Yeast based assays are useful for detecting DNA-protein and protein-protein 
interactions. Although yeast-based assays are sensitive, substantial amount of artifacts 
often hinder the correct interpretation of the results. The first part of the project was 
focused on the validation of yeast one-hybrid and two- hybrid assay and assessment for 
the possible source of artifacts. We found that media sources and preparation methods 
had significant influence on the results to yeast-one-hybrid and yeast-two hybrid assay. 
Using condition optimized yeast-two hybrid assay to match in vivo experiments, 
we examined protein interactions formed by Ubx, a protein with intrinsically disordered 
regions. In the classical protein structure-function paradigm, protein function is 
determined by particular protein structure. However, some proteins do not have rigid 
structure, and these proteins extensively interact with proteins with diverse functions. 
The second part of this dissertation was focused on dissecting the topological features of 
binding partner of an intrinsically disordered protein, Ubx. We found that the binding 
partners of Ubx protein were enriched in particular folds and disordered regions on Ubx 
protein were essential for Ubx-partner protein interactions, which may explain why 
proteins with multiple binding partners often have disordered regions.  
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Ubx protein not only interacts with other proteins but also with itself. This self-
association has been explored for the application for tissue engineering purposes. The 
cytocompatible and biocompatible characteristics of Ubx self-assemble protein materials 
could provide an unmet need for 3-dimensional (3D) scaffolds on which to culture 
cancer cells for carcinogenesis characterization. The third part of this dissertation was 
focused on determining the compatibility between isogenic human mammary gland cell 
lines with various degrees of tumorigenesis and characterization of cell behavior on Ubx 
materials. We found that Ubx materials were not toxic to human mammary gland cells 
with similar genetic background but different degree of tumorigenesis. In addition, Ubx 
materials enabled further characterization of cancer cell specific cell behaviors. 
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NOMENCLATURE 
2D 2-dimensional 
3D 3-dimensional 
Abd-A Abdominal-A 
AkUbx Akanthokara kaputensis Ultrabithorax 
Al Aristaless 
Aly Always early 
Antp Antennapedia 
Apt Apontic 
Arm Armadillo 
BRCA Breast cancer 1 
CBP CREB-binding protein 
CBP80  Cap-binding protein 1 
c-Ha-ras p21 protein coding gene 
CM Challenged mouse 
CNS Central nervous system 
CREB cAMP response element-binding protein 
CycK Cyclin K 
DAPI 6-diamidino-2-phenylindole 
Dfd Deformed 
DIC Differential interference contrast 
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DIP1 Disconnected-interacting protein 1 
Dll Distal-less 
DMEM/F12 Dulbecco's Modified Eagle Medium/ Nutrient Mixture F-12 
DmUbx  Drosophila melanogaster Ultrabithorax 
DNA Deoxyribonucleic acid 
DPBS Dulbecco's phosphate-buffered saline 
Dsh Dishevelled  
DTT Dithiothreitol 
ECs Endothelial cells 
EF1γ Elongation factor 1γ 
Ef2b Elongation factor 2b 
EGFP Enhanced Green Fluorescent Protein 
eIF4E Ribosome recruiting protein RNA 
eIF4E-BP2 Eukaryotic translation initiation factor 4E-binding protein 2 
ELISA Enzyme-linked immunosorbent assay 
EMSA Electrophoretic mobility shift assay 
En Engrawolberiled 
Exd Extradenticle 
FP3.38  Anti-homeodomain antibody 
Fzo Fuzzy onions 
GPa Giga pascal 
HCV Hepatitis-C Virus   
viii 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Hox Homeobox 
HRP Horseradish peroxidase 
HSC70-4 Heat shock protein cognate 4 
Hth Homothorax 
IgG Immunoglobulin G 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
Kd Equilibrium dissociation constant 
kDa Kilo dalton 
Keap1 Kelch-like ECH-associated protein 1 
KP       Potassium phosphate    
Mdm2 Mouse doubles minute 2 homolog/ E3 ubiquitin-protein ligase 
Meis Meis homeobox  protein 
MMP Matrix metalloproteases 
MMPs Matrix metalloproteases 
mRpL44 Mitochondrial ribosomal protein L44 
Nmo Nemo 
NMR Nuclear magnetic resonance 
NO Nitric oxide 
Noc  No ocelli 
Nrf2 Nuclear factor erythroid 2-related factor 2 
Nrt  Neurotactin 
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NS5A   Non-structural protein 5A  
MoRF  Molecular recognition feature  
ONP   o-Nitrophenol  
ONPG  ortho-nitrophenyl-β-galactoside p21 
Otu   Ovarian tumor  
p120ctn   Adherens junction protein p120  
PBC    Pre B cell proteins 
Pbx   Pre-B cell leukemia transcription factor 
PCs   Pericytes  
PK17E   Protein kinase-like 17E  
PONDR  Predictor of Naturally Disordered Regions 
PRM   Proline-rich motif  
ProTα   Prothymosin α  
PS6   Parasegment 6 
RpL22  Ribosomal protein L22  
Rpn6   Protease p44.5 subunit  
Rps13  Ribosomal protein S13 
Sal   Spalt  
SCOP   Structural Classification of Proteins  
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH3   SRC homology 3 domain   
SMCs   Smooth muscle cells  
x 
Smox  Smad on X 
SRC Proto-oncogene tyrosine-protein kinase 
TALE Three amino acid loop extension 
Term  Terminus 
TFIIEβ  Transcription factor IIEβ 
TGFβ-1 Transforming growth factor β-1 
TNF-α Tumor necrosis factor-α 
Trn  Transportin 
Ubx  Ultrabithorax 
UM  Unchallenged mouse  
VAMP Vesicle-associated membrane protein 
VAP  Vesicle-associated membrane protein (VAMP)-associated protein 
VAPB Vesicle-associated membrane protein-associated protein B 
X-gal 5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside 
YNB Yeast nitrogen base 
Zf30C Zinc finger protein 30 
Zn72D Zinc-finger protein at 72D 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Introduction 
Proteins control and coordinate biological functions in living organisms. Protein-
protein interactions often regulate diverse in vivo functions including, but not limited to: 
transcription regulation, cell signaling, chemical analysis, and cell structure. A single 
protein may execute different functions: for example, many transcription factors repress 
and activate transcription in a context-specific manner [1-4].  How can a single protein 
execute multiple functions? One possibility is that protein function can be regulated by 
protein-protein interactions [5-7]. However, many proteins without rigid structure, called 
intrinsically disordered proteins, have multiple regulatory and signal transduction 
functions [8-11]. 
The first part of this literature review will focus on discussing different types of 
protein-protein interactions, the role of intrinsically disordered regions in facilitating 
context-specific function of Homeotic (Hox) protein, and molecular functions of a Hox 
protein, Ultrabithorax (Ubx). In addition to the endogenous biological functions 
executed through protein-protein, protein-protein interaction is essential to material 
formation and different materials formations can be observed among different protein 
building blocks. The second part of this literature review will focus on the general 
review on a variety of protein based materials and Ubx self-assemble protein materials. 
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Moiety of Protein- Protein Interactions 
The structure function paradigms states that the unique amino acid sequence 
provide the unique structure of a protein, which determines the function of this protein. 
When a structured protein interacts with another structured protein requires the 
complimentary shape and proper surface chemistry, a concept is known as “lock and key 
ˮ model, a concept extended from enzymatic activity to macromolecule interactions 
[7,12]. The interface is composed of complementary shapes, and stabilizing hydrophobic 
hydrogen bonds, and ionic interactions. This type of protein interactions is commonly 
involved in critical biological functions such as enzymatic catalysis, immunological 
recognition, and receptor/ligand interactions [13-15]. However, transcription factors and 
cell signaling proteins often have disordered regions [11]. The following section will 
focus on reviewing literatures describing the role of disorder in protein-protein 
interaction. 
Structured-disordered or disordered-disordered protein interaction 
Proteins without rigid structure also carry out important biological functions such 
as cell signaling and transcription regulation.  Statistical data has shown 66% of cell 
signaling proteins and >80 % of transcription factors are intrinsically disordered or have 
large disordered regions [11,16]. In addition, intrinsically disordered proteins are often 
involved in human diseases. Mis-regulation in intrinsically disordered proteins often 
causes catastrophically consequences [17]. These relationships seen in: p53, p21, and 
BRCA in cancer, prion protein in prion diseases, α-synuclein in synucleinopathies, and 
Tau protein in Alzheimer's disease etc. [17-19]. It is reasonable to wonder what 
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characteristics of intrinsically disordered proteins caused so many diseases. The 
inherited structural flexibility of intrinsically disordered protein provides the significant 
advantage in protein-protein interaction, which is the binding promiscuity [20,21]. 
Intrinsic disorder provides the conformational plasticity for biological functions such as 
transcription regulation and cell signal transduction [11,22]. Furthermore, intrinsically 
disordered regions are modified by posttranslational modifications and alternative 
splicing [23]. The flexibility of the intrinsically disordered proteins presents the higher 
probability for the required biological modification on the peptides or amino acids which 
ultimately imprint the functions of the protein. Ultimately, these modifications have the 
potential to regulate partner binding by the intrinsically disordered protein.   
A disordered protein can form extensive interactions with numerous proteins, 
known as the “one to many” concept [20,24]. The p53 protein is a good example because 
it has been extensively studied with detailed structural data available on multiple partner 
interactions [25-27]. The malfunction of p53 is linked to carcinogenesis including but 
not limited to colon, lung, esophagus, breast, liver, brain, and hemopoietic tissues 
[25,28-33]. Large disordered regions can be found at the N- terminal domain and C-
terminal domain of p53 protein (Figure 1.1). A comparison of  order/disorder tendencies 
in p53 as revealed by PONDR disorder prediction algorithm together large scale 
bioinformatics study reveal that over 70% of p53 partners interact with disordered 
regions [20]. Individual disordered regions in p53 can change their conformations when 
they interact with different partners [18]. For example, the disordered C-terminal of p53 
interacts with multiple proteins by conformational changes at individual disordered 
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regions, which has gone through a structural transition from disordered to secondary 
structures [34-36].  The type of secondary structure formed by this single disordered 
region include: a helix when associating with S100ββ, a β sheet with sirtuin, and distinct 
irregular structures with CBP and cyclin A2 [20] (Figure 1.2). 
Figure 1.1 p53 protein disorder predictions. Two different prediction algorithms 
in PONDR predictors, VLXT  and VSL2P, are shown as solid line and dashed line, 
respectively [20]. 
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Figure 1.2 Conformational changes of single disordered regions in 
the C-terminal of p53. Primary, secondary, and quaternary structure of p53 
disordered region complexes are depicted for each [18]. 
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Figure 1.3 Alignment of multiple disordered sequences 
with single binding groove in 14-3-3ξ domain. This complex 
include peptide from histone H3, serotonin N-acetyltransferase 
(AANAT), a phage display-derived peptide (R18), and motif 1 
(m1) and motif 2 (m2) peptides [20]. 
        In addition to one disordered region interacting with multiple proteins, many disordered 
regions can also bind an individual structured region. A cell signaling protein with large 
disordered regions, 14-3-3 protein family, which is conserved among eukaryotic cells, 
interacts with more than 200 proteins such as kinases, proteases, and phosphatases to 
execute diverse regulatory functions including but not limited to signal transduction, 
apoptosis, cell cycle progression, DNA replication, and cell malignant transformation 
[37,38]. About 90% of 14-3-3 proteins interacting partners have at least one intrinsically 
disordered region [39]. Figure 1.3 shows that five disordered region from other binding 
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sequences associated with single structured domain on 14-3-3. The wide array of partner 
proteins indicate that the intrinsically disordered characteristics of 14-3-3 protein indeed 
provides extensive binding ability for 14-3-3 [20].   
Fuzzy complexes   
Disordered proteins can also form transient and dynamic complexes with binding 
proteins. These complexes are considered as “fuzzy” complexes [40,41]. A stable 
protein binding complex requires the balance between the cost of entropy and gain of 
enthalpy which lead to the continuous search of the best docking interface and 
conformations. These conformations can be classified by the degree of dynamics of the 
protein complex [40]. For example, the association of Hepatitis-C Virus (HCV)  non-
structural protein 5A (NS5A) and VAPB, an RNA alternatively spliced isoforms of 
vesicle-associated membrane protein associated protein (VAP), form a fuzzy complex 
[42]. NS5A is involved in viral RNA replication with 2 large disordered regions 
including the domain 2 and domain 3 of NS5A. A dynamic complex is formed between 
the intrinsically disordered domain 3 of NS5A and the well-structured MSP domain of 
VAPB. Another good example is the dynamic protein complex formed by Prothymosin 
α (ProTα) and Kelch-like ECH-associated protein 1 (Keap1) [43]. Prothymosin α 
(ProTα) is an oncoprotein with most of peptides intrinsically disordered in unbound 
state. ProTα retains a high level of flexibility even in the bound state with Kelch, which 
is in agreement with the molecular dynamic (MD) simulations of the ProTα–Kelch 
complex [43]. 
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 Liquid-protein self-assembly 
Multivalent interactions are involved in pivotal biological functions such as: 
extracellular matrix ligand-receptor interactions, intracellular signaling transduction, 
RNA metabolism and chromatin organization in the nucleus [44-46]. Furthermore, 
multivalent interaction could be the driving force in protein polymerization. 
Figure 1.4 Time-lapse imaging of merging PRM4-SH34 peptide 
droplets. The merging process of individual droplets composed of  
PRM4 and SH34 peptides can be seen in the time-lapse pictures. Scale 
bar, 10 mm  [47]. 
In polymer chemistry, valency and affinity of molecular control the phase 
transitions of monomeric species. Monomeric molecules have sharp phase 
transformation from small assembles to large gel like materials, known as the sol-gel 
transition. Similar interactions are also formed by intrinsically disordered protein 
interactions [44,47].  For example, SRC homology 3 (SH3) domain interact with its 
proline-rich motif (PRM) ligand generates hierarchal species in an concentration 
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dependent manner [44]. At critical concentration, SH3 and PRM ligand go through 
liquid-liquid de-mixing transition which generates micrometre-sized polymer droplets in 
buffer. Large scale polymerization can also be created by increasing concentration of 
monomeric SH3 peptide and PRM ligand for prolonged incubation (Figure 1.4). This 
observation may explain how intrinsically disordered proteins react to other proteins at 
extremely high concentrations and why they have modest affinity at interactions. In 
addition, the multivalent properties can also be used for protein with multiple partner 
proteins to execute the proper function at the right tissues and right time. The following 
review will provide introduce the concept of context-specific function using Hox protein 
family as an example, and Ubx protein, a Hox transcription factor, as the model protein 
for this research. 
Context Specific Function 
Homeotic genes regulate animal developmental function in multiple tissues and 
execute different functions dependent to tissue or/and developmental stage [48-50]. Mis-
regulation of these genes likely causes serious consequences such as developmental 
deficiency which of represent the transformation of one structure at region of the body 
into another [51-56]. For example, ectopic expression of the Hox gene, Ubx, at the eye-
antennal imaged disc of Drosophila melanogaster generates a pair of legs in place of the 
antennas are; however mis-expression of Ubx in the third thorax region causes the 
formation of extra wing (Figure 1.5) [57,58]. Therefore, in the eye-antennal imaginal 
disc, Ubx represses genes that generates antenna and activates genes required to 
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construct a leg. In contrast, in halteres, Ubx represses genes required to form the wing 
and activates genes required to form halteres. Thus Ubx regulates different groups of 
genes based on the tissue in which it is expressed. 
Figure 1.5 Phenotype of wild type and homeotic mutant Drosophila 
melanogaster. (A)Wild-type male Drosophila melanogaster have the haltere, small club-
shaped organs located posterior to the wings at the 3
rd
 thoracic segment. (B) The mis-
expression of Ubx at the 3
rd
 thoracic segment creates a mutant in an adult Drosophila
melanogaster with extra pair of wing replaces the halters and 3
rd
 thoracic segment [58].
Hox  family as a model system for context specific studies 
Hox proteins target a wide variety of genes in a stage specific manner such as: 
growth-factor-like molecules, membrane receptors, cell adhesion molecules, structural 
proteins and many other transcription factors [48,52,59,60]. Hox proteins can be found 
in bilateral organisms, in which the protein specifies the identity of the segment in 
bilaterally symmetric organisms [61]. The examples of how different tissues controlled 
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by evolutionally conserved Hox genes with functional overlap are shown in Figure 1.6. 
Mouse Hox 2.2 gene, an orthologue of Antp in mouse, effectively induces the homeotic 
transformation of Drosophila Antp in the thoratic segment in Drosophila embryos and 
larvae by Antp-Hox 2.2 chimera expression vector with a hybrid promoter. Mouse Hox 
4B gene, an orthologue of Dfd is able to restore its orthologue Dfd’s function in 
Drosophila embryos using a similar hybrid construct. 
Figure 1.6 The four HOX gene clusters found in mammals are conserved from the 
Drosophila HOM-C complex in terms of nucleotide sequence and expression. During 
embryonic development, the genes (color blocks) are expressed in a pattern along the 
anterior to posterior axis that correlates with the position in the Hox gene cluster [62].  
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Hox protein cofactors and DNA binding specificity 
Hox proteins recognize the 5’-TAAT-3’ consensus sequence with relatively high 
DNA affinity [63-66]. The isolated DNA binding homeodomain of Hox proteins can 
bind the target DNA sequence with pM affinity [65,66]. Known for the low specificity 
due to the consensus DNA target sequence for most Hox proteins but requirement for a 
high degree of specificity in vivo, there are other factors in play of providing Hox protein 
with specificity in transcription regulation [67,68]. One of the possible mechanisms is 
through interacting with Hox cofactors [69,70]. A group of well-known Hox cofactors 
are the three amino acid loop extension (TALE) homeodomain proteins [71,72]. The 
TALE proteins have ability to binding DNA and they are evolutionally conserved in 
common model organisms. Two TALE proteins can be found in Drosophila include 
Extradenticle (Exd) and Homothorax (Hth). In contrast, there are four Exd-related 
proteins (Pbx1, Pbx2, Pbx3, Pbx4) and five Hth-related proteins (Meis1, Meis2, Meis3, 
Prep1, and Prep2) in the mouse [73]. Exd and Pbx proteins are also known as pre B cell 
(PBC) proteins. 
 Structural and in vivo studies have indicated a motif common to most Hox 
proteins, YPWM motif, makes direct contacts with the TALE motif in PBC 
homeodomain [71,74-79]. The Hox YPWM motif (also called Hexapeptide motif) forms 
a reverse turn and binds within a pocket formed by the 3
rd 
and 4
th 
helices of the divergent 
homeodomain of the Pbc protein[78]. In Drosophila Ubx, a motif C-terminal to the 
homeodomain mediates additional contacts with Exd [80]. Besides TALE family 
homeodomain proteins, the Drosophila Engrawolberiled (En) protein has also been 
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shown to be a Hox cofactor as well [81]. En bound cooperatively with both Ubx and 
Abd-A to a regulatory element from the Dll gene, and En input is required for Dll 
repression in the posterior compartments of the abdominal segments [81,82]. 
Ultrabithorax Molecular Functions and Features 
The longest translational product of Ubx gene (Ubx Ib) has 389 amino acids, 60 
of which compose the conserved homeodomain [79,83,84]. The regions of Ubx outside 
the homeodomain have significant biological functions such as transcription activation, 
protein interaction and transcription repression [Mann 1990, Galant 2002, Beachy 1993, 
Bondos 2004]. The primary function of the homeodomain is to interact with DNA. 
Previous studies have shown that Ubx homeodomain target DNA with consensus 
sequences of 5’- TAAT-3’ with tight affinity as the value of  Kd=  7x10
-11
 M [84]. Ubx
protein binds targeted DNA sequences cooperatively with each other [83]. 
Electrophoretic mobility shift assay (EMSA) using Ubx protein and oligonucleotides 
with 5’-TAAT-3’ DNA sequence clusters have demonstrated the formation of multi-Ubx 
proteins composed complex by individual Ubx proteins [83]. Furthermore, the half-life 
of the Ubx DNA complex increase significantly for multi-site target DNAs. In addition 
to cooperative binding by individual Ubx proteins, like other Hox proteins, Ubx protein 
also binds DNA cooperatively with other cofactors for specific binding. For example, 
Exd protein facilitates the Ubx-DNA binding and vice versa to Hox-Exd composite 
DNA sites [85,86].  
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Ubx protein structure and intrinsically disordered feature 
About 44% of the Ubx protein sequence is intrinsically disordered. The more 
structured homeodomain is composed of loops and helixes to form helix-loop-helix 
structure (Figure 1.7) [78]. Disordered regions are found throughout the remaining Ubx 
sequence with most of them situated at the transcription regulatory regions in Ubx [65]. 
These disordered regions have direct effect on Ubx-DNA binding affinity and specificity 
[66]. The full length Ubx protein has weaker DNA binding affinity than Ubx truncated 
mutants with homeodomain alone or mutants with shorter sequence surrounding the 
homeodomain region. 
Figure 1.7 An overview of the Ubx -Exd-DNA ternary complex. 
The diagram shows the Ubx (red) and Exd (cyan) homeodomains 
binding in a tandem manner on opposite faces of the DNA (yellow). The 
dashed red line represents the disordered linker between the Ubx 
homeodomain and its YPWM motif [78]. 
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mRNA alternatively spliced isoforms of Ubx 
Immunohistochemical staining experiments using the isoform-specific antibodies 
demonstrated that Ubx isoforms la and lb are expressed primarily in the epidermis, 
mesoderm, and peripheral nervous system during embryonic development; whereas 
isoforms IIa and IIb are expressed primarily in the central nervous system and isoform 
IVa is expressed exclusively in the CNS (Figure 1.8) [87]. Class IIa and IVa RNAs and 
proteins increase in abundance during later stages with distinct expression patterns in the 
CNS. Ubx IIa and IVa RNA and protein expression decrease from the posterior to 
parasegment 6 (PS6) in Drosophila. In addition, there are strong differences in the level 
of expression of class IVa RNA and protein in different cells within a given neuromere, 
whereas IIa RNA and protein show a more uniform level of expression within each 
neuromere. These experiments confirm that individual neurons within each neuromere 
express quantitatively different combinations of Ubx IIa and Ubx IVa. In particular, 
detailed studies have shown that isoforms Ia and IVa differ quantitatively in their ability 
to direct development of the peripheral nervous system, Ia being able to carry out this 
function more effectively than IVa [88]. Large scale protein interactions not only 
important for executing biological function, it may also be utilized for material 
formation. The following sections will describe different type of protein materials. 
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Figure 1.8 Schematic representations of natural and non-natural Ubx isoforms 
and expression domain in vivo. Dashed lines represent the missing microexon(s) in 
different isoforms [87,89]. 
Protein-Protein Interactions in Protein Materials 
Protein-Protein interactions are not only involved for cellular regulatory 
functions but can also serve as a building block for cellular structure and tissue 
architectures. Many protein materials are cytocompatible, and biocompatible, thus could 
be developed as tissue engineering scaffold for regenerative medicine and other medical 
purposes [90-94]. A variety of protein materials are available for these applications, each 
with different properties. The following literatures review will provide overview for the 
properties and applications for protein based materials. 
Elastin  
Elastin proteins form elastic fibers in soft tissues, such as blood vessels, skin, and 
lung [95]. Due to the biocompatibility and cytocompatibility, elastin has been explored 
for the following applications including but not limited to cartilage and intervertebral 
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disc tissue engineering, vascular graft tissue engineering, ocular tissue engineering, and 
cell sheet engineering [96-99]. Elastin is formed from soluble precursor protein, 
tropoelastin (60-73 kDa) which is a type of extra cellular membrane proteins. 
Tropoelastin can be found in elastingenic cells such as smooth muscle cells, fibroblasts, 
and endothelial cells [100]. Varieties of elastin protein have been isolated from animal 
tissues or expressed in the precursor form using recombinant technology. Tropoelastins 
aggregate under physiological salt concentration at neutral pH and 37°C when the 
tropoelastin proteins reach the 10% weight/water concentration to form elastin [101]. 
Tropoelstin contains a nonpolar hydrophobic core with repeat motifs such as 
(GVGVP])n and (GXXPG)n, where X could be lysine or valine residues. The 
hydrophilic domains with high content of lysine residues mediate the crosslinking of 
elastin and stabilize the structure, and provide mechanical strength (Figure 1.9) 
[102,103]. 
Figure 1.9 Elastins sequence and structure. Elastins sequence include 
repeats such as [GVGVP]n which can form β-spiral structure [104]. 
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Collagens 
Collagen is one of the most abundant proteins found in animals with up to 35% 
of whole body protein. There are 29 different types of collagen (TypeI- TypeVII) 
identified and each type of collagen has different functions primarily in mammalian (e.g. 
skin, bone, blood vessels, cartridge, and tendon) [105]. Collagen have been widely used 
for biomedical and tissue engineering purposes such as tissue engineering scaffolds, 
antibody production, drug delivery platform, and 3D cell culture scaffolds [106-108]. 
Collagen is composed of right-handed triple-helix fibril called tropocollagen. Individual 
tropocollagen fibril is formed by collagen α chain triple helix segment from either 
(GPX)n or (GXX) amino acids sequence repeats, where X could be any amino acid other 
than glycine, proline or hydroxyproline (Figure 1.10) [105,109]. Tropocollagen fibrils 
are intertwined to form a right-handed triple helical collagen bundle. Polymerization of 
collagen can be physical, enzymatic, and chemical through the modification of the amine 
and carboxyl groups to form covalent bonds between the tropocollagen fibrils. 
Figure 1.10 Collagens sequence and structure. Collagens show 
sequence repeats such as (GPX)n and triple-helix structure [104]. 
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Fibrin 
Fibrin protein is used as the function of assists the blood clotting. The application 
of fibrin for medical purpose dates back to early 19th century for healing battleground 
[110]. Since then, it has been applied as a tissue engineering scaffold purposes including 
but not limited to: cardiac tissue engineering, bone reconstruction, muscle tissue 
engineering, skin engineering, ocular tissue engineering, and vascular tissue engineering 
[111,112]. The advantages of using fibrin as materials include biocompatible, 
biodegradable, mimic the extracellular matrix, and easy to transport the nutrition to cells. 
Since fibrin is isolated from animals and not purified as a recombinant protein, the 
possibility of transferring pathogens and endogenous material inconsistency often 
require modifications during material production [113]. 
Silk from silkworms and spider 
Silk is composed of fibrous proteins and generated by constant pulling and 
spinning by silkworm from the posterior end glands of organisms [114]. Silk has been 
widely tested for a variety of applications such as: tissue engineering scaffolds, 
platforms for drug delivery and in vitro disease models [90,104,115,116].  Liquid- like 
silk proteins form β-sheet crystallite after dehydration, which happen after the liquid-like 
silk protein leaves the body of silkworm. These proteins are highly soluble in vivo 
compared with other proteins, which can reach a concentration of 30% over w/v without 
protein aggregation [117,118].  Silk protein can be stored in soluble liquid form at 
moderate temperature in silkworm for several weeks without premature formation of 
crystallites, which is a common problem for generating silk fibers in vitro [115]. Silk 
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crystallite formation can be induced by changing the physical and chemical 
environments. Changes of temperature, force, pH or addition of organic solvents can 
instigate the polymerization of silk fibroin proteins [115,119]. The primary structure of 
silk protein from Bombyx mori silkworms include the disordered repetitive sequence 
GAGAGSGAAG[SG(AG)2]8Y with polar and charged  flanking amino acids residues 
and an alanine rich hydrophobic core in the middle of peptide which from pleated β 
sheet (Figure 1.11) [104]. The formation of silk fibril starts begins with the micelle 
formation of multiple silk proteins. Dehydration process and sheer force enhance the 
hydrophobic association between individual silk fibroin which facilitates polymerization 
of silk fibroin micelle into silk fibers [114,120]. One of the most notable features for 
spider silk is the strength and toughness. For example, the spider silk is as strong as 
engineered steel with a strength to weight ratio at 1.1 GPa compared to 1.3 GPa from 
engineered steel. In addition, spider silk is tougher than Kevlar 81 fibers with a tested 
value at~ 165 k Jkg
-1
 compared to 33 k Jkg
-1
  for  Kevlar 81 fibers [121].
Figure 1.11  Spider and silkworm silks sequence and structure. Spider and 
silkworm silks show sequence repeats such as (GAGAGS)n or (AAAAA)n, and 
beta-pleased sheet crystal structure [104].  
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In addition of silkworms, spiders, bees, ants, and hornets can also generate silks with 
diverse structure and properties [122,123]. 
Ultrabithorax Protein Materials 
Most protein materials are form by scaffold proteins which have inherited 
characteristic to support cellular structure.  However, many proteins, other than scaffold 
or structure supporting protein, can also form materials. For example, Ultrabithorax 
(Ubx) protein, a transcription factor from Hox proteins family, can self-assemble into 
materials in vitro [124]. The following section will focus on illustrating Ubx self-
assemble protein materials. 
Ubx readily self-assemble into material and can be functionalized 
Ubx proteins self-assemble and form hierarchy structure between air-liquid 
interfaces. Ubx protein does not need extreme condition such as high temperature, 
extreme pH or chemical reagents to facilitate the polymerization [124]. Ubx protein can 
form fibrils in phosphate based buffer at physiological condition such as room 
temperature and pH 7.4. Monomeric Ubx protein self- assembles into fibril 50 nm in 
diameter at air-liquid interface after 1 hour incubation under physiological relevant 
condition. Under suitable protein concentration (0.075 mg/mL and 0.6 mg/mL), Ubx 
fibrils can form films, sheets, and eventually ropes. In addition, Ubx can also form more 
complex structures such as bundles, lattices, and encapsulates [124]. Regarding the 
mechanical properties, individual Ubx protein self-assemble rope can be stretched to an 
additional 53% (±19%) of their original length before fracturing, which is more elastic 
22 
than silkworm silk, spider silk, and collagen [124].  Ubx materials can also tolerate 
98°C, indicating the fibers are mechanical robust under extreme condition. Ubx 
materials can be functionalized using molecular biological approaches. Ubx fusion 
proteins can be created by standard molecular cloning. Several Ubx chimera proteins 
have been successfully created, including myoglobin, luciferase, mCherry, and EGFP 
[125]. 
Ubx is cytocompatible 
Ubx-mCherry chimera fibers are not toxic to three different human cell lines 
including primary human aortic smooth muscle cells, primary human umbilical vein 
endothelial cells, and primary human brain vascular pericytes [126].  Ubx fibers can 
accommodate these three different cell types after prolong incubation without killing 
cells (Figure 1.12) [127]. 
Ubx materials is biocompatible 
Ubx materials are biocompatible [127]. Ubx fibers attract very low levels of 
immune cells when they are implanted into mice. Ubx fibers are stable in host animal for 
prolong incubation. Western blotting and enzyme-linked immunosorbent assay (ELISA) 
indicated below detectable level of antibodies against Ubx in the sera from mice 
implanted with Ubx protein fibers (Figure 1.13). In additinn, Ubx fibers cultured with 
macrophages in vitro do not lyse or activate the macrophages, measured by TNF-α and 
NO secretion, which indicate low level of immunoresponce triggered by Ubx fibers . 
Finally, Ubx fibers do not induce hemolysis when co-incubated with red blood cells 
[127]. This dissertation will focus on the role of intrinsically disordered regions in 
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protein binding by Ubx and application of Ubx protein materials in establishing 3D cell 
culture. Studies, including validation of a high-throughput assay for identification of 
regions in Ubx protein, exploration for selection criteria for Ubx proteins and 
identification for domains in Ubx proteins, which interact with other proteins, as well as 
characterization of cell behaviors on biomaterials formed by self-assemble Ubx proteins 
will be discussed in this dissertation. 
Figure 1.12 Ubx fibers accommodate cells regardless of the cell type. Ubx 
fibers are marked with blue arrows. Endothelial cells (ECs) (A and B), aortic 
smooth muscle cells (SMCs) (C and D), and brain vascular pericytes (PCs) (E and 
F) growing on plain Ubx fibers were immunostained for α- tubulin (green) and
stained with DAPI (blue). In all cases, the cytoskeletons are normal and roughly 
aligned with Ubx fibers. Scale bars: (A) 20 µm; (B, E, and F) 10 µm; (C and D) 50 
µm [126]. 
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Figure 1.13 Ubx materials are stable in host animals implanted with Ubx 
materials. (A-D)  Each panel shows a western blot using a different source for 
primary antibodies to determine whether antibodies are present that can detect 
Ubx. (E)  ELISA assays show no detectable level of antibody in mice implanted 
with Ubx materials. The purified anti-homeodomain antibody (FP3.38) was used 
for positive control and purified donkey anti-mouse IgG HRP antibody was used 
for negative control. UM (1-4) represent unchallenged mouse and CM (1-4) 
represent challenged mouse serum. Dilution factors for primary antibody  or 
mouse serum are 1:100 (blue), 1:1000 (red), and 1:10000 (green)[127]. 
25 
CHAPTER II 
MEDIA COMPOSITION INFLUENCES YEAST ONE- AND TWO-HYBRID 
RESULTS* 
Introduction 
 The yeast two-hybrid system provides an efficient method for identifying novel protein-
protein interactions in small-scale studies and high-throughput screens [128-130]. In this 
system, the first hybrid is composed of a bait protein fused to a DNA binding protein 
that recognizes DNA sequences upstream of a lacZ reporter gene. The second hybrid 
protein consists of a strong activation domain fused to a potential protein partner. 
Interaction between bait and partner proteins localizes the strong activation domain to 
the lacZ promoter, thus activating transcription of the lacZ reporter gene. Multiple cycles 
of lacZ transcription, translation, and β-galactosidase cleavage of X-gal generate visible 
quantities of the blue assay product, 5-bromo-4-chloro-3-hydroxyindole. This sensitive 
system detects interactions that may be difficult to observe by other means (e.g., co-
immunoprecipitation) due to low abundance of the protein complex. The sensitivity of 
this method can also lead to several problems: (i) transformation efficiency affects signal 
strength and is highly dependent on technique [131], (ii) 25% to 50% of detected 
interactions are estimated to be false positives [132,133], and (iii) 55% to 90% of true 
protein interactions are not observed (false negatives) [129,133]. 
*Reprinted with permission from “Media Source Profoundly Influences the Outcome of Yeast One- and
Two-Hybrid Experiments” by Liu, Y, Merchant, Z, Hsiao, H-C, Gonzalez, KL, Matthews, KS, and 
Bondos, SE., 2011. Journal of  Biological Procedures Online 13, 6. Copyright 2011 by Biomedical Central 
Ltd. DOI 10.1186/1480-9222-13-6  
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Identifying sensitive parameters in yeast two-hybrid experiments could help 
address these difficulties. Herein, we report both the source of media components and 
the media preparation protocol can impact yeast one-hybrid and two-hybrid results. 
In the yeast one-hybrid system, the bait protein, which includes a transcription 
activation domain, is fused to a DNA binding protein [128]. When the protein of interest 
is hybridized to a DNA binding domain, this assay can be used to assess the presence 
and strength of an activation domain [134]. Alternately, the protein of interest can be 
hybridized to a strong activation domain to screen for DNA binding [135]. The yeast 
one-hybrid method requires transformation of only one plasmid, resulting in improved 
transformation efficiency and fewer cellular manipulations[130]. This simpler 
experimental design reduces experimental variability, allowing focus on systematic 
issues that arise using this method. 
Materials and Methods 
Media were prepared according to the protocol in Table 2.1 and Table 2.2 with 
varying parameters as discussed below. EGY48-p8op-lacZ yeasts were transformed as 
previously described [132,134,136]. The genome of this reporter host strain (EGY48) 
includes a wild-type LEU2 gene under the control of a series of LexA operators. The 
reporter plasmid p8op-lacZ, which carries the lacZ gene under the control of LexA 
operators, had been stably transformed into this strain [134]. For each DNA tested, cells 
from a single transformation were divided between plates for each condition to ensure 
that commonly cited error sources, such as interactions with endogenous proteins, auto-
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activation, and low transformation efficiencies [128-130], did not contribute to 
differences in results. The resulting blue color of yeast colonies, which reflects the level 
of transcription activation, was gauged with a standard color chart (Figure 2.1). Analysis 
by color chart yielded data comparable to analysis by enzyme assay. All experiments 
were repeated at least three times and yielded consistent results. Yeast nitrogen base 
sources were Sigma (Y1251-100G), Difco (233520), and Clontech (630421). 
The procedures for making different yeast media plates are similar, but the identity of 
the dropout supplements, sugars, and antibiotic can vary.  Since we have used the 
Clontech pLexA Matchmaker yeast two hybrid system, we must replace glucose with 
galactose and raffinose to induce chimera expression. 
Table 2.1 Yeast media preparation protocol. 
Step Procedures 
1 Add 300 ml water to a 1 L flask. 
2 Using a stir plate, stir continuously without heat while adding: 
a. 0.85 g yeast nitrogen base without amino acids or ammonium sulfate (Difco #233520).  The 
impact of using yeast nitrogen base from other companies is discussed in the accompanying 
paper. 
b. 2.5 g Ammonium sulfate (Mallinkrodt Chemicals, 7725)
c. 10 g Galactose (Acros, 150611000) 
d. 5 g raffinose (Acros, 1956171000) 
e. 0.375 g –His/-Ura/-Trp dropout supplement (Clontech, 630424) 
3 Bring the final volume to 445 ml. 
4 Add 10.5 g agar (Fisher Scientific, BP1423).  The new volume should be approximately 450 ml. 
5 Autoclave at a setting of 1.27 kg/cm2 at 121 ºC for 15-30 minutes. Clontech recommends 15 minutes, but we use 30 
minutes without adverse effects. 
6 Allow the flask to cool down.  It is sufficiently cool when you can comfortably touch the bottom of the flask – where 
the liquid is located – to the inside of your arm (preferred method), or you can hold the flask in your hands for 30 
seconds.  If you proceed to step 7 too quickly, you will destroy the heat-sensitive reagents. 
7 Using a sterile hood, add the following reagents while swirling the flask to prevent local cooling / solidification of the 
agar: 
f. 500 µl of 50 mg/ml kanamycin monosulfate (CRPI, K22000) for a final concentration of 50
µg/ml 
g. Turn off hood and room lights to add 0.4 ml of 50 mg/ml X-gal (Progene V3941).  X-gal is light
sensitive.  If you make your own X-gal solution, use DMSO or DMF as a solvent.  Either way,
your X-gal solution should be clear.  If you see traces of brown, it should be discarded.
h. 50 ml 0.7M KP buffer*.
*The preparation of KP buffer is described in Table 2.2.
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Table 2.2 KP* buffer preparation protocol. 
Step Procedures 
1 Make 1 M K2HPO4 by dissolving 17.4 g of K2HPO4 (Sigma, P9666) to a final volume of 100 ml. 
2 Make 1 M KH2PO4 by dissolving 13.6 g of KH2PO4 (Sigma, P9791) to a final volume of 100 ml. 
3 Use a heated stir plate to dissolve both salts.  Do not heat above 50 degrees.  Do not heat after all 
of the salt is in solution. 
4 Mix 61.5 ml of 1 M K2HPO4 with 28.5 ml KH2PO4. 
5 Adjust the pH to 7.0 if necessary using the leftover 1 M salt solutions. 
6 Dilute the resulting 1 M solution at pH=7.0 to 0.7 M. 
7 Filter sterilize the resulting buffer using a 0.20 or 0.22 micrometer cutoff filter into an autoclaved 
flask or bottle. 
8 KP buffer should be stored at 4 ºC used within one month and discarded if visibly contaminated. 
*KP buffer is severed as a reagent to stabilize the pH in yeast media plates
Figure 2.1 Evaluation of results by colony color.  (A) 
Color chart used to standardize colony assessment. (B) Color analysis 
yields results comparable to quantitative assays for β-galactosidase 
activity, reported in Miller units.  Miller units were calculated as 
specified in the Clontech yeast transformation protocol (PT3024-1). 
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Results 
Effects of yeast nitrogen base source on yeast-one hybrid experiments 
We first compared media in which the yeast nitrogen base (YNB) was produced 
by different companies and the pH was adjusted after sterilization to ensure consistency 
between media preparations. In general, media made with YNB from Sigma yielded the 
strongest signal in yeast one-hybrid experiments, whereas media made with Difco YNB 
yielded intermediate results, and media made with Clontech YNB produced the weakest 
signal (Table 2.3, Conditions 1-3). We began experiments using pLexA-Gal4, in which 
DNA encoding the LexA DNA binding domain is fused to DNA for the Gal4 
transcription activation domain. Expression of this hybrid protein should produce a 
strong positive signal. At only 48 hours post-transformation, yeast colonies transformed 
with pLexA-Gal4 appeared light blue on media made with Sigma and Difco, whereas 
colonies on the Clontech media remained white. After 60 hours post-transformation, 
pLexA-Gal4 colonies on Sigma and Difco media were medium blue, and the colonies on 
the Clontech media were light blue. Although the results from Difco and Clontech media 
became indistinguishable after 72 hours, colonies on the Sigma plates were still darker 
blue. While the source of YNB made a consistent difference, using different lots from 
the same supplier had no impact on results (Table 2.4). To determine whether this media 
effect is unique to LexA-Gal4, we next tested LexA-Ubx, in which LexA is fused to the 
Drosophila Hox protein Ultrabithorax (Ubx), which activates transcription at a moderate 
level to yield medium blue colonies [134]. Colonies transformed with pLexA-Ubx 
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yielded a similar trend as pLexA-Gal4: colonies on media containing Sigma and Difco 
YNB were the first to show blue color (Table 2.3, Conditions 1-3). 
Table 2.3 Yeast one-hybrid results are strongly dependent on media.  
Yeast 
Nitrogen 
Base 
pH 
adjustment
1 
48 hrs observation 60 hrs observation 72 hrs observation 
Gal4 Ubx Pro-2 Gal4 Ubx Pro-2 Gal4 Ubx Pro-2 
1 Sigma + ++ – – +++ + – ++++ ++ ++ 
2 Clontech + – – – ++ – – +++ ++ ++ 
3 Difco + ++ – – +++ + – +++ ++ ++ 
4 Sigma – +++ – – ++++ +++ ++ ++++ +++ ++ 
5 Clontech – ++ + – +++ ++ + +++ ++ ++ 
6 Difco – – – – ++ – – ++++ +++ – 
We examined six media conditions, defined by yeast nitrogen base supplier and 
pH adjustment post-autoclave.  Difco media can yield false negative data (condition 6) 
and the other media preparations can yield false positives (conditions 1-5) compared to 
other transcription activation assay methods[134].  “pH” refers to the pH of the 0.7 M 
potassium phosphate buffer (KP); “Gal4” stands for pLexA-Gal4, the positive control 
plasmid expressing the DNA binding domain of LexA fused to the Gal4 transcription 
activation domain (Clontech).  “Ubx” represents the pLexA-Ubx plasmid, “Pro-2” is the 
negative control, in which proline mutations disrupt transcription activation by the 
LexA-Ubx hybrid . The blue shade of colonies is reported here as symbols: “++++” for 
dark blue, “+++” for medium blue, “++” for light blue, “+” for pale blue, and “–” for 
white colonies.  See Figure 1. for color standards. The pH after autoclaving but before 
addition of KP was 4.67, 5.11, and 4.31 for Sigma, Clontech, and Difco media, 
respectively. After addition of KP buffer post-autoclaving, the pH of all media was 6.7 ± 
0.1.  For conditions 1-3, the pH was adjusted to 7.0.  Therefore pH differences are not 
the source of the supplier-based differences in results. 
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Table 2.4 Different lots media with no different results. 
Lot 
number 
Experiatio
n date 
48 hrs observation 60 hrs observation 72 hrs observation 
Gal4 Ubx Pro-2 Gal4 Ubx Pro-2 Gal4 Ubx Pro-2 
144069 12-31-2004 – – – ++ – – ++++ +++ – 
7116446 10-30-2012 – – – ++ – – ++++ +++ – 
8190329 11-30-2012 – – – ++ – – ++++ +++ – 
9194329 6-30-2014 – – – ++ – – ++++ +++ – 
Yeast one-hybrid experiments yield consistent results using yeast nitrogen base 
from the same supplier (Difco), even with different lot numbers and expiration dates (the 
first one well past due).  When preparing the media, no significant differences in pH 
were observed either before autoclaving or after adding KP buffer. 
As a negative control, we used LexA-Pro2 in which LexA is fused to a Ubx 
variant containing mutations A223P/Q224P/T225P/A228P, which disrupt a predicted α-
helix required for transcription activation [134]. Importantly, these proline mutants also 
prevent transcription activation by Ubx in a promoter-reporter assay in Drosophila S2 
cells, corroborating the yeast results [134]. Whereas we expected colonies expressing 
LexA-Pro2 to be white, colonies grown on all three types of media were light blue after 
72 hours. Consequently, the sensitivity of the signal to changes in media appears to 
depend on the strength of transcription activation: the strongest activator, LexA-Gal4, 
generated the largest differences, whereas results for the weakest activator, Pro2, were 
independent of YNB source for this media preparation method. 
Based on our prior results, we expected to see a wide range of color: dark blue 
(++++) for LexA-Gal4, medium blue (+++) for LexA-Ubx, and white (-) for LexA-Pro2 
[134]. However, the results for wild-type and mutant Ubx were similar at 72 hours post-
transformation in all three conditions. Furthermore, colonies expressing LexA-Gal4 were 
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lighter than expected when grown on Clontech and Difco media. Thus, the range of 
signal strengths appears poor for Conditions 1-3 (Table 2.3). 
Effects of adjusting media ph on yeast-one hybrid experiments 
Strikingly, simply not readjusting the pH after sterilization resulted in 
amplification of the signal range.  Comparing results for wild-type and mutant Ubx, a 
slight difference in signal was again observed in Sigma media which persisted to 72 
hours (Table 2.3, Condition 4).  However, using Difco YNB without pH re-adjustment 
not only increased the signal range at 72 hours but also matched prior results in yeast 
and Drosophila cell culture [134].  Specifically, for Condition 3 (Difco, no pH 
adjustment), the data ranged from light blue (++, Ubx and Pro-2) to medium blue (+++, 
Gal4), whereas for Condition 6 (Difco, pH adjustment), the data ranged from white (-, 
Pro-2) to dark blue (++++, Gal4). 
Even without readjusting the pH, media using YNB sources did not replicate 
previous data in yeast and Drosophila cell culture.  Consequently, media choice can 
influence the prevalence of false positives and false negatives.  Expression of the LexA-
Gal4 positive control correctly yielded a strong positive signal at 48 hours on Sigma 
media, but a false negative signal on Difco media.  Likewise, although LexA-Ubx 
expression rapidly generates a positive signal on Sigma plates, expression of LexA-Ubx 
on Difco plates gives a false negative response at 60 hours post-transformation, although 
a positive signal eventually develops after longer incubations.  Consequently, the 
researcher could miss this signal, since the pLexA-Gal4 positive control produces signal 
at 60 hours.  Conversely, the Ubx mutant Pro-2, which should not activate transcription, 
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yields a false positive signal on Sigma media at after 60 hours incubation.  Therefore, by 
not re-adjusting the pH after autoclaving, we observed a greater overall range of signal, 
greater media-dependent differences in signal, and greater differences in signal between 
transcription activators of different strengths. 
Media effects on yeast-two hybrid experiments 
Given that the source of the YNB had a profound impact on the results observed 
in a yeast one-hybrid assay, we reasoned that differences in media might partially 
account for the variations in data originating from different laboratories in yeast two-
hybrid experiments [130,134].  Testing this possibility, we examined the impact of the 
media source in yeast two-hybrid experiments using a set of control plasmids, in which 
the T-Antigen-B42 activator chimera should bind a LexA-p53 chimera but not a LexA-
Lamin chimera.  Similar to yeast one-hybrid experiments, we found the results of yeast 
two-hybrid data were also dependent on media (Table 2.5).  
At five days after transformation, only media produced with Clontech YNB 
yielded a positive signal, and at six days after transformation, colonies on Clontech 
media had the strongest signal and Sigma media consistently yielded the weakest signal.  
Surprisingly, this trend is opposite that observed for yeast one-hybrid experiments, 
suggesting either the two experimental methods are differentially sensitive, or the 
magnitude of the media effect is influenced by the proteins assayed. 
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Table 2.5 The source of yeast nitrogen base also impacts yeast two-hybrid results. 
Yeast 
Nitrogen 
Base 
pH 
adjustment 
5 days 
observation 
6 days 
observation 
p53 LAM p53 LAM 
1 Sigma – – – + – 
2 Clontech – + – +++ – 
3 Difco – – – ++ – 
 In this assay using control plasmids provided by Clontech, pB42AD-T-Antigen 
should bind pLexA-53, in which the p53 protein is fused to LexA, resulting in blue 
colonies [137].  Conversely, T-Antigen should not bind Lamin produced by pLexA-
LAM [138]. 
Discussion 
In summary, we have demonstrated that i) media components and preparation 
methods influence yeast one- and two-hybrid experiments, ii) for yeast one-hybrid 
experiments, this media sensitivity scales with increasing activation domain strength, 
and iii) media can determine the range of signal observed in yeast LacZ reporter assays.  
Such differences are sufficient to change data interpretation: experiments that should 
yield a negative result may appear positive, or vice versa.  We observed media-
dependent effects in four systems: yeast one-hybrid experiments using either the Gal4 
activation domain, wild-type Ubx, or a Ubx mutant lacking activity, and finally yeast 
two-hybrid experiments reporting on the p53-T-antigen interaction.  Therefore, this 
media sensitivity occurs across a wide range of yeast experiments and may contribute to 
differences in yeast two-hybrid results observed previously [129,137].  Our results for a 
single yeast nitrogen base source are consistent even when testing different lot numbers 
or chemicals differing in age by a decade, suggesting that the differences we observe 
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when the source of the yeast nitrogen base is changed are significant.  Since each 
manufacturer reports the same yeast nitrogen base composition, these differences may be 
attributed to differences in contaminants of these media components.  These experiments 
suggest that careful reporting of chemical sources and preparation methods for yeast 
media is essential to enable replication of experiments and comparison of data between 
studies.  Finally, these media-dependent differences in results could be exploited to 
enhance and thus verify weak differences in signals from yeast assays.
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CHAPTER III 
THE INTRINSICALLY DISORDERED REGIONS OF THE DROSOPHILA 
MELANOGASTER HOX PROTEIN ULTRABITHORAX SELECT INTERACTING 
PROTEINS BASED ON PARTNER TOPOLOGY* 
Introduction 
Most biological processes are implemented and regulated by macromolecular 
complexes, in which proteins are major components.  The function of an individual 
protein, therefore, is often determined by the identity and range of the proteins to which 
it binds [70,131,139].  Consequently, proteins must specifically and reliably bind the 
correct partners in vivo [65,66,140,141].  Interactions between structured proteins 
require complementary topologies that generate sufficient interfacial surface area 
[13,142-144] and complementary surface chemical groups capable of creating stable 
interprotein bonds [7,145].  Residues forming an interface between two structured 
proteins are often less dynamic relative to non-interfacial surface residues, even when 
the proteins are in the unbound state [142]. 
Intrinsically disordered proteins and protein regions are present in more than one 
third of protein complexes and are enriched in proteins with multiple partners 
[10,22,146-154].  
*Reprinted with permission from “The Intrinsically Disordered Regions of the Drosophila melanogaster
Hox Protein Ultrabithorax Select Interacting Proteins Based on Partner Topology” by  Hsiao H-C, 
Gonzalez KL, Catanese DJ Jr, Jordy KE, Matthews KS, and Bondos SE., 2014 PLOS ONE 9 
(10):e108217. Copyright 2014 by Public Library of Science. DOI:10.1371/ 
journal.pone.0108217  
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As monomers, these proteins lack stable globular structures and rapidly 
interconvert among a large ensemble of conformations.  Disordered protein monomers 
can sample structure present in the bound complex or be extremely dynamic with little 
detectable canonical structure [43,155,156].  The disordered region may fold to similar 
structures present in all interactions, or a single disordered region may adopt many 
different structures to bind protein partners with different topologies [157-161].    
In contrast to the complementary interface formed by two folded proteins, a 
subset of disordered regions remain highly dynamic even when bound, either initially 
through an induced-fit binding mechanism [159,162] or as part of a heterogeneous final 
complex [40,163-165].  This structural heterogeneity in the complex has been proposed 
to be an essential component of fine-tuning the function of the complex [163] as well as 
maintaining the sensitivity of the complex to evolving cellular signals [166].  The 
extreme malleability of intrinsically disordered regions, even in the bound state, raises 
questions regarding the role of the structure and surface topology of the partner protein 
in these interactions.  Indeed, disordered proteins bind more types of protein structures 
(folds) than do structured proteins [167]. 
In this paper, we explore the importance of partner topology in protein 
interactions mediated by Ultrabithorax (Ubx), a Drosophila melanogaster Hox 
transcription factor.  Ubx is composed of both structured and disordered regions 
[65,78,134].  Amino acids 1-102 of Ubx, herein termed Region 1, include a mixture of 
short structured elements interspersed with disordered sequences.  Region 2 is a large 
disordered region, spanning amino acids 103 to 216 and including a portion of the 
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transcription activation domain [134].  A putative α-helix required for transcription 
activation is located in Region 3 [134].  Amino acids 250-303, termed Region 4, 
encompass intrinsically disordered, alternatively spliced microexons and the disordered 
N-terminal arm of the homeodomain.  Finally, the C-terminal Region 5 includes the 
structured portion of the homeodomain.  Based on native state proteolysis rates, the 
disordered regions of Ubx are significantly more exposed than the disordered regions of 
proteins that fold upon ligand or co-factor binding [65].  Moreover, Region 2 is 
extremely glycine rich (27%, including 13 contiguous glycines).  Polyglycine peptides 
are compact, yet very dynamic, and lack stable intra-protein contacts [168,169].  
Because the extent of monomer disorder correlates with the degree of disorder present in 
the bound state [162,170,171], the extremely dynamic disordered regions in Ubx are 
unlikely to fold into a stable structure upon partner protein binding.  
Ubx is a “one-to-many” protein, in that it physically interacts with 39 known 
partner proteins with a wide variety of molecular functions [6,78,79,172,173].  This 
large number of partner proteins provides a sufficiently diverse sample to identify 
common traits that enable binding to Ubx. Several of these interactions have been 
validated in vivo [6,79,132].  Proteins that genetically interact with Ubx, unsupported by 
physical interaction data, were not included in this study since genetic interactions can 
arise from processes other than physical interaction between proteins.  We found that 
specific folds are significantly enriched in Ubx-interacting proteins.  Single domains of 
the partner protein that exhibit the selected fold are sufficient to bind Ubx.  Interestingly, 
the intrinsically disordered regions of Ubx are necessary for these protein interactions.  
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Although partners bind all three disordered regions cooperatively, individual partner 
proteins rely on specific disordered regions to varying extents, creating opportunities for 
competition and collaboration in forming higher order complexes.  Regions 1 and 2 are 
multiply phosphorylated, providing another mechanism to regulate partner binding in 
vivo.  Partner binding also varies among Ubx isoforms arising from ubx mRNA splicing, 
providing a third regulatory mechanism.  Interestingly, the preference of protein partners 
for specific Ubx isoforms correlates well with the topology of the partner protein.  Thus, 
phosphorylation and alternative splicing, both tissue-specific processes, have the 
potential to regulate protein interactions.  The regions of Ubx involved in partner 
binding also regulate DNA binding and include a portion of the transcription activation 
domain [65,66,134].  Linking different Ubx functions via intrinsically disordered regions 
has the potential to provide the specificity and reliability required for Hox activity in 
vivo. 
Materials and Methods 
Definition of intrinsically disordered regions of Ubx 
Ubx disordered regions were defined by a combination of prediction algorithms 
and experimental assays.  Disordered and structured regions were predicted using the 
average score from three programs, VLXT-PONDR, IUPRed, and DisEMBL 
(loops/coils) [65].  Predicted amino acid residues with an average prediction score ≥ 0.6 
are designated disordered.  A residue with an averaged prediction score between 0.4 and 
0.6 was considered as uncertain and thus was not defined in this study. A residue with an 
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average prediction score ≤ 0.4 was considered structured.  Native state proteolysis data 
[65] were used to refine the predicted boundaries of disordered and structured regions. 
Since successful proteolysis requires a minimum of five disordered amino acids on both 
sides of the severed bond, the regions designated as disordered were expanded at a few 
positions to include these sequences.  The designations of structure and disorder agree 
with previous data on the locations of structure in the Ubx homeodomain, the partially 
structured nature of the HoxB1 FPWM motif in the absence of Pbx1 binding (analogous 
to the Ubx YPWM motif which was designated as “uncertain” by our analysis), and the 
location of a putative α-helix involved in transcription activation by Ubx [78,134].  
Protein interface and molecular recognition features were predicted by the Anchor and 
MoRFpred algorithms, respectively [6,173]. 
Classification of the Drosophila interactome by fold 
 The Drosophila melanogaster large-scale yeast two-hybrid dataset [172] was 
used for this global analysis.  The structural assignments, definitions, and evolutionary 
relationships listed in Flybase [174] and the Structural Classification of Proteins (SCOP) 
database version 1.65 release 3 were used to group the proteins by folds.  SCOP merges 
computer algorithms and human curation to classify protein domains based on structural 
and evolutionary similarities. Interaction maps were generated and modified using 
Osprey 1.20 (http://biodata.mshri.on.ca/osprey/servlet/Index).  
Databases built using Microsoft Access were used to construct the figures and 
tables in the Supporting Data, which can be accessed from http://rice.allgeek.net.  
Algorithms to analyze the raw protein interaction data were written using Windows 
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Visual Basic 6.0.  The genome database was compiled from a list of all Drosophila 
genes downloaded from Flybase.  If the Flybase reference for the corresponding protein 
had one or more assigned folds as defined by SCOP, then all potential fold-fold pairs 
were included in the database.  Any structure assignments that were fragments of other 
folds, “not a true fold”, or duplicates of other entries were eliminated.  By this analysis, 
roughly one quarter of Drosophila proteins have an assigned fold.  Each fold in 
multifold proteins was included in the genome database, accounting for 23% of the 
proteins, and was listed as an interacting fold for all interactions in which the multifold 
protein participates, yielding 63% of the total interactions examined. The interactome 
database contains previously defined interactions and includes the confidence score 
assigned to that interaction by Giot et al. [172].  Data fitting for the scale-free graph was 
completed using Igor Pro Version 4.02A (WaveMetrics). 
Classification of Ubx protein interactions by fold  
Proteins with assigned folds that physically interact with Ubx included data from 
Giot et al. [172], our laboratory [132,136], and other laboratories [79].  Proteins encoded 
by genes that only genetically interact with ubx were not included, because molecular 
events other than protein interactions can yield a genetic interaction.  Folds within this 
protein list were identified as described above. 
Yeast two-hybrid assays 
Ubx deletion and truncation mutants were created using the QuikChange site-
directed mutagenesis kit following manufacturer instructions (Agilent).  Ubx variants 
were cloned into the pLexA plasmid (Clontech) between the EcoRI and BamHI 
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restriction enzyme sites. Ubx binding partners had previously been cloned into the pB42 
vector [Bondos 2004, Bondos 2006].  DNA encoding the individual domains of Al 
(residues 81 to 142) and Arm (residues 155 to 273) were synthesized by Blue Heron 
Biotechnology Inc., USA. 
Ubx variants and partner plasmids were co-transformed into EGY48 
Saccharomyces cerevisiae already carrying the p8op-LacZ reporter plasmid (Clontech).  
In this process, 500 l of an overnight liquid culture of yeast (OD600 nm ≈ 1.5) was 
centrifuged, and the pellet was washed with 2 mM lithium acetate (Acros) and 100 mM 
dithiothreitol (DTT, Fisher Scientific).  Cell pellets, re-suspended in 100 l of 
transformation reaction mix, containing 2 mM lithium acetate, 50% polyethylene glycol 
(Sigma, MW3350), 10 g/ml salmon sperm DNA (Sigma), and 100 mM DTT, were 
mixed with Ubx-pLexA plasmid and Ubx binding partner pLexA fusion (500 ng per 
plasmid). The resulting mixture was incubated at 46 °C for one hour and subsequently 
centrifuged.  The pellet was re-suspended in sterile water and spread on a designated 
synthetic amino acids drop-out yeast medium agar (2%) plate containing 80 g/ml of X-
gal (Research Products International) following incubation for 5-6 days at 30 °C.  
The blue or white color of the colonies provided an initial qualitative measure of 
binding.  The results of this qualitative assay matched subsequent quantitative results 
using the Miller -galactosidase reporter assay [175].  In this assay, an individual yeast 
colony was used to inoculate 5 ml of the designated synthetic amino acid drop-out yeast 
medium, then grown overnight at 30 °C with 250 rpm shaking to an OD600nm ≈ 1.5.  -
Galactosidase liquid assays generally followed the Clontech Yeast Protocols Handbook 
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(Clontech).   In brief, 2 ml of the overnight yeast culture were used to inoculate 8 ml of 
the trp
-
/his
-
/ura
-
 drop-out yeast medium containing 10% galactose (Sigma) to activate the
B42-partner chimera and 5% raffinose (Sigma) to provide a carbon source and incubated 
at 30 °C for 3-5 hr with 250 rpm shaking until the cells reached mid-log phase with 
OD600 nm ≈ 0.8.  To harvest the yeast culture, 1.5 ml was removed and centrifuged 10,000 
x g for 30 seconds. Supernatant was discarded and the pellet was mixed thoroughly with 
1.5 ml of Z Buffer (70 mM Na2HPO4, 40 mM NaH2PO4• H2O, 10 mM KCl, 1.3 mM 
MgSO4).  After re-centrifugation and decanting the supernatant, the pellet was re-
suspended in 300 l of Z Buffer, divided into three 100 l aliquots, frozen in liquid 
nitrogen for 1 minute, and incubated at 37 °C for 45 seconds.  This freeze and thaw 
process was repeated two more times. To the cell lysate, 4 mg/ml of ortho-nitrophenyl-
-galactoside (ONPG, Sigma) in Z Buffer and 700 l of 27% -mercaptoethanol in Z 
buffer were added, followed by 30 °C incubation with mixing by inversion every 10 
minutes.  -Galactosidase expression levels were assessed by enzymatic assays that 
spectroscopically measure generation of the -galactosidase enzymatic product, o-
nitrophenol (ONP), at 420 nm.  When yellow color was visible, reactions were quenched 
by addition of 400 l of 1 M Na2CO3.  The elapsed time from the beginning of the 
reaction (ONPG addition) to the end of reaction (Na2CO3 addition) was recorded. The 
reaction mixture was centrifuged at 10,000 x g for 10 minutes. Supernatant was collected 
and A420 nm was recorded. The results were reported in Miller units, the amount of -
galactosidase that hydrolyzes 1 μmol of ONPG to ONP per min per cell. 
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Miller units were calculated using the following formula: 
  
   nm
nm
ODVt
A
Activity
600
4201000
in which t is the elapsed time (in min) of incubation, V is 0.1 ml x dilution factor (5 for 
this protocol), OD600 nm is the optical density of 1 ml induction culture before harvest 
measured at a wavelength of 600 nm, and A420 nm is absorbance of 1 ml ONPG reaction 
product measured at 420 nm. 
Western blotting  
Extraction of yeast protein samples and their preparation for western blotting 
followed the Yeast Protocols Handbook (Clontech). Cells were lysed as described for 
yeast two-hybrid assays, and whole cell lysate was subsequently centrifuged at 10,000 x 
g for 10 minutes to remove cell debris and any insoluble Ubx.  Proteins were separated 
by SDS-PAGE prior to western blotting with a 1:200 dilution of LexA murine 
monoclonal primary antibody (Santa Cruz Biotechnology) followed by a 1:5,000 
dilution of IRDye 800CW Goat anti-Mouse IgG (H + L) secondary antibody (Li-Cor). 
Protein expression was visualized and quantified using an Odyssey infrared imaging 
system and software (Li-Cor). 
Results 
Ubx selects protein interactions based on partner topology 
The Drosophila Hox protein Ubx is 44% intrinsically disordered, and binds 
many partner proteins [79,132,136,176].  However, the location and chemical nature of 
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most of these protein interfaces is unknown.  To determine which physicochemical 
properties of partner proteins are important for mediating these interactions, we first 
examined the characteristics of Ubx-binding proteins (Figure 3.1).    
Although some of the Ubx partner proteins form true interactions that alter Ubx 
function in vivo [132,136,171], other interactions have not been examined in flies.  In 
addition, a few interactions are unlikely to be biologically relevant because the partner 
has a different sub-cellular localization and / or is involved in unrelated biological 
processes.  However, binding by all partners results in similar reporter intensities in 
yeast two-hybrid assays, reflecting similar protein interaction affinities.  Ubx is 
presumably able to bind the unlikely partners in vitro because these proteins share 
features recognized by Ubx when it binds the true partners.  Therefore, including these 
unlikely partners in the analysis increases the occurrence of traits selected by Ubx while 
simultaneously decreasing the occurrence of traits commonly found in transcription 
factors but not specifically required for Ubx binding. Of the 39 known Ubx binding 
proteins [6,78,132,136,172,173], 34 have domains with assigned folds.  We searched for 
properties common to these 34 Ubx partners.  Ubx has a predicted net charge of + 7.3 at 
pH = 7.4.  This strong positive charge is largely due to the DNA-binding homeodomain 
(+11 at pH = 7.4), the only large structured region within Ubx.  Any proteins directly 
binding the homeodomain would be expected to have a compensating negative charge.  
Ubx partners have a surprisingly large range of predicted net charges at pH = 7.4, 
spanning +36 to -54 (Figure 3.2).  Thus, net charge does not correlate with the ability to  
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Figure 3.1 Location of structured and disordered regions in UbxIb, and design of Ubx variants. (A) A grey 
bar, representing the domain organization of the UbxIb transcription factor shows the position of its transcription 
activation domain (blue), YPWM Exd interaction motif (yellow), DNA-binding homeodomain (black), a partial 
transcription repression domain (orange), and protein regions encoded by three alternatively spliced microexons: the b 
element (pink), mI (purple), and mII (brown).  (B) The location of predicted protein-interaction motifs in Ubx as 
predicted by ANCHOR (yellow stripes) and MoRFpred (blue stippled stripes).  Regions predicted by both algorithms 
to be involved in protein interactions are marked with both yellow and blue.  (C) A bar schematic depicting the 
positions of structured and intrinsically disordered regions in UbxIb.  The boundaries were determined by a 
combination of computational and experimental approaches.  The scores from three disorder prediction algorithms 
were averaged to identify structured (green) and disordered (red) regions.  Native state proteolysis, in which only 
disordered segments can be cleaved by trypsin, was used to verify these assignments, and, where appropriate, slightly 
expanded the boundaries of the predicted disordered regions [65].  Sites cut by trypsin (▼), sites not cut by trypsin (
), and sites that could not be definitively assigned (▼) are indicated.  (D) Bar schematic for predicted protein 
interfaces and molecular recognition features (MoRFs) on Ubx peptide. The schematic bars show Anchor algorithm 
predicted Ubx- partner protein interfaces (orange bars) and MoRF algorithm predicted Ubx-partner protein interface 
(blue bars with pattern fill). (D) Bar schematics of Ubx truncation mutants and internal deletion mutants used in yeast 
two-hybrid assays to identify partner binding interfaces. UbxIb, UbxIa, and UbxIVa are isoforms created by 
alternative splicing in vivo.  To prevent auto-activation, the activation domain was de-activated either by removal of 
amino acids 102 to 216 or by the Pro4 mutation, in which Ala and Glu are mutated to Pro at amino acids 226 and 233 
(indicated by a red-green stipple), respectively, which should prevent formation of a predicted -helix required for 
transcription activation [134].   In two variants, the structured C-terminus of the protein was replaced by mCherry, 
represented by a pink/white striped bar. 
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bind Ubx, suggesting that all partners are unlikely to exclusively bind the 
positively charged homeodomain. Topology is a key factor affecting interactions 
between structured proteins, and sorting protein interactions based on the folds of the 
interacting partners can yield useful information about the nature of the interactions. 
Using the terminology of the Structural Classification of Proteins (SCOP) hierarchical 
classification database [176] , analysis of Ubx partners at the level of protein folds 
reveals that 23 of the 34 Ubx binding partners contain one of just 7 different folds, out of 
the 1195 folds identified by SCOP (Table 3.1, Table 3.2).  All of the selected folds in 
Ubx-interacting proteins are enriched relative to the frequency with which these folds 
occur in the Drosophila proteome (Table 3.3).  However, this level of enrichment may 
not be specific to Ubx: some folds are more prevalent in the Drosophila interactome.  To 
determine whether these folds are more likely to bind Ubx than a random protein, we 
compared the extent of fold enrichment among Ubx partners with data derived from a 
high-throughput yeast two-hybrid experiment on Drosophila proteins [172] (Figure 3.3).  
Grouping the high-throughput data by fold did not change the scale-free nature of the 
network (Figure 3.4).  The DNA/RNA binding 3-helical bundle fold, the α-α superhelix 
fold, and the dsRNA binding motif fold occur more frequently among Ubx-interacting 
proteins than in the Drosophila interactome, indicating that the enrichment of these folds 
among Ubx partners is not an artifact of their increased propensities to bind proteins in 
general (Table 3.3).  For Ubx and each protein in the Drosophila interactome, we also 
calculated the number of folds each protein binds (F) divided by the number of proteins 
each binds (I) (Figure 3.5).  Proteins with an F/I ratio approaching 1 do not select 
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partners by topology, whereas proteins with a low F/I ratio are highly selective.  
Whereas Ubx has an F/I ratio of 0.61, approximately 90% of the proteins analyzed have 
a higher F/I ratio, indicating they are less selective than Ubx.  Despite the fact that large 
regions within Ubx are disordered and presumably extremely dynamic, these results 
suggest that topology is an important criterion by which Ubx selects protein partners.  
Figure 3.2 Ubx binds both positively and negatively charged proteins.  The chart shows the 
predicted net charge at pH = 7.4 of Ubx and the subset of its partner proteins with known folds 
[79,132,136].  Abbreviations: Al, Aristaless; Aly, Always early; Apt, Apontic; Arm, Armadillo; CycK, 
Cyclin K; CBP80, Cap-binding protein 1; Dsh, Dishevelled;  DIP1, Disconnected-interacting protein 1; 
Ef2b, Elongation factor 2b; EF1 γ, Elongation factor 1γ; Exd, Extradenticle; Fzo, Fuzzy onions; mRpL44, 
Mitochondrial ribosomal protein L44; HSC70-4, Heat shock protein cognate 4; Nmo, Nemo; Noc, No 
ocelli; Nrt, Neurotactin; p120ctn, Adherens junction protein p120; Otu, ovarian tumor; PK17E, Protein 
kinase-like 17E; RpL22, Ribosomal protein L22; Rpn6, Protease p44.5 subunit; Rps 13, Ribosomal 
protein S13; Smox, Smad on X; Term, terminus.  
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Table 3.1 Specific folds are enriched in Ubx-binding proteins. 
Fold Partner Fold Partner 
DNA/RNA binding 3-
helical bundle 
RpL22 
Apt 
P-loop containing NTP 
hydrolases 
EF2b 
Mi-2 
Al Fzo 
Dsh 
Ubx dsRBD-like DIP1 
Exd mRpL44 
α-α superhelix Arm Ferridoxin-like EF2b 
Rpn6 Aly 
P120ctn 
CBP80 Protein kinase-like Nmo 
14-3-3ε Pk17E 
Zinc-Finger C2H2 and 
C2HC 
Noc 
Zf30C 
Zn72D 
Term 
Exd is a well-established Ubx binding protein [79], and Ubx cooperatively binds 
DNA [83].  All other Ubx binding partners were identified by yeast two-hybrid assays. 
Ubx binding partners were classified by the fold/shape according to SCOP. Folds with 
more than one partner were defined as “selected”. The interactions with Term, Fzo, 
mRpL44, and Pk17E were reported by Giot et al. [172].  The remaining interactions 
were reported by Bondos et al. [132,136].   
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Table 3.2 Ubx partners with non-selected folds. 
Fold Partner    Fold Partner 
FYVE/PHD zinc 
finger 
Mi-2  Ribosomal protein S5 domain  2-
like 
Ef2b 
HLH-like Hairy  Ribonuclease H – like motif Hairy 
Cyclin-like CycK  α/β-Hydrolases Neurotactin 
XPC-binding 
domain 
Rad23  Chromo domain-like Mi-2 
S15/NS1 RNA 
Binding Domain 
RpS13  Smad/FHA domain SMOX 
β-Grasp Rad23  Reductase/isomerase/elongation 
factor    
 common domain 
Ef2b 
Smad MH1 domain SMOX  PDZ domain-like Dsh 
A fold with only one partner was classified as a non-selected fold. Folds for 
Ubx binding partners were classified according to SCOP. 
51 
Figure 3.3 Maps of a large-scale Drosophila melanogaster yeast 
two-hybrid data  parsed by fold, in which dots represents specific folds, 
and lines between dots depict interactions between the connected folds. 
All fold•fold interactions with a confidence score of at least 0.5 are shown. 
Intrafold interactions are depicted as loops which connect back to the 
originating node.   
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Figure 3.4  Probability distribution curves for Drosophila protein 
interactions from a large-scale yeast two-hybrid experiment parsed by fold.  Data 
were fit to a truncated scale-free model.  The scatter observed at high k is often 
observed in scale-free systems [172,177].  The similarity of these graphs to each 
other and with the protein data [172] indicates that grouping data by structure do 
not alter network character.  Graphs depicting the number of superfamilies, 
proportional to P(k), that have k interactions is shown as an inset.  Deviations from 
a straight line in these graphs are indicative of biological restrictions on highly 
interactive proteins within a scale-free network.  
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Table 3.3  Comparison of the occurrence of folds in the Drosophila proteome and 
interactome.  
Fold Frequency 
in 
Drosophila 
proteome 
Frequency 
in 
Drosophila 
interactome 
Frequency 
in Ubx 
partner list 
P-value of 
enriched 
fold  
relative to 
Drosophila 
proteome 
P-value of 
enriched fold  
relative to 
Drosophila 
interactome 
DNA/RNA 
binding 3-
helical 
bundle 
2.7% 8.4% 17.6%    P<0.05 0.05<P<0.1 
α-α 
superhelix 
3.4% 7.2% 14.7% P<0.05 0.05<P<0.1 
Zinc Finger 
C2H2 and 
C2HC 
3.7% 11.7 % 11.8% P<0.05 0.05<P 
dsRBD-like 0.2% 0.9% 5.9% P<0.05 P<0.05 
Protein 
kinase-like 
2.8% 5.6% 5.9% 0.05<P 0.05<P 
p-loop 
containing 
NTP 
hydrolases 
5.6% 8.4% 8.8% 0.05<P 0.05<P 
Ferridoxin-
like 
2.8% 8.1% 5.9% 0.05<P 0.05<P 
p-value of enriched fold relative to Drosophila proteome/interactome was 
generated using Chi-Squared test.   
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Figure 3.5 The distribution of the fold to interaction ratio (F/I). (A) 
All single domain proteins. (B) All single domain proteins with more than 
one partner. Proteins with a high ratio do not select protein partners by fold, 
whereas interactions with proteins with a low ratio have strong fold 
preferences. Ubx has an F/I ratio of 0.61, indicating a strong ability to 
select partners by fold. 
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Importantly, proteins unlikely to naturally bind Ubx can have the same fold as 
true Ubx partners.  For example, DIP1 alters transcription regulation by Ubx in cell 
culture assays and inhibits Ubx function in vivo [136].  DIP1 has the same fold as 
mRpL44, a mitochondrial ribosomal protein that should not co-localize with Ubx in 
vivo.  Therefore, even if some Ubx-protein interactions lack a biological role, they can 
still yield information regarding the physicochemical properties of partner proteins 
bound by Ubx in vivo.  This phenomenon underscores the importance of partner 
topology in the selection of protein partners by Ubx. 
The enrichment of particular folds among Ubx partners may be caused by Ubx 
preferring to bind the surface topologies created by these folds.  Alternately, the types of 
proteins Ubx binds in vivo, transcription factors and cell signaling proteins, may be 
enriched in these folds (e.g., a DNA/RNA binding 3-helical bundle fold).  Consequently, 
the “selected folds” may be enriched among Ubx partners due to their cellular function 
rather than presentation of a binding interface on the surface of the selected fold.  In 
order to determine whether the selected folds are sufficient to mediate Ubx interactions, 
we used yeast two-hybrid assays to probe whether Ubx interacts with the regions of 
partner proteins that correspond to the selected topology.  We utilized the yeast-two 
hybrid method because (i) these assays do not interfere with Ubx binding to these 
partners, (ii) these assays do not rely on other Ubx functions, such as DNA binding or 
transcriptional regulation, iii) yeast two-hybrid assays allow quantitative comparison of 
the strength of binding, and (iv) many partners identified by yeast two-hybrid assays also 
alter Ubx function in vivo [79,132,136,178], demonstrating this method likely reflects 
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native protein interactions involving Ubx.  We created two constructs: a single - 
superhelix domain from Arm (amino acids 155-273) and a DNA/RNA binding 3-helical 
bundle domain from Al (amino acids 81-142).  We hypothesized that the individual 
domain in an Ubx partner is sufficient to interact with full-length Ubx without 
surrounding sequences.  To prevent reporter gene activation by Ubx in the absence of 
partner binding, a full-length Ubx mutant (UbxIb Pro4) was used that is incapable of 
transcription activation [134].  Individual yeast two-hybrid experiments between these 
two isolated domains and UbxIb Pro4 [134], exhibit similar levels of reporter gene 
expression as for experiments in which UbxIb Pro4 binds the corresponding full-length 
partners (Figure 3.6). This result indicates that the - superhelix and DNA/RNA 
binding 3-helical bundle folds in these proteins are sufficient for Ubx interaction. 
Our general approach is to remove either intrinsically disordered or structured sequences 
within Ubx (Figure 3.1) to assess whether these regions impact binding to protein 
partners.  All of the Ubx mutants were carefully designed to minimize the impact on 
regions of Ubx structure that are well-folded.  In the N216 and N103 Ubx truncation 
mutants, amino acids 2-215 (Regions 1 and 2) or 2-102 (Region 1) are removed, 
respectively (Figure 3.1).  These variants have been successfully used for both in vitro 
DNA binding assays and yeast one- and two-hybrid experiments [65,134].  Indeed, both 
truncation mutants are soluble, active monomers capable of binding DNA with an 
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Figure 3.6 An individual partner domain is 
sufficient for Ubx binding.  Full length Al and Arm have 
similar interaction strength as individual domains derived 
from Al (residues 81-142) and Arm (residues 155-273) 
with UbxIb Pro4. The intensity of the β-galactosidase 
reporter gene, reported as Miller Units, signal for each 
partner is similar to its respective single-domain variant.  
affinity comparable to full-length Ubx [65].  Similarly, we made Ubx variants with an 
internal deletion (103-216) which removes Region 2.  Other Ubx mutants with internal 
deletions in this region are also soluble and capable of binding DNA [65].  Furthermore, 
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the length of this region is significantly reduced in natural Ubx orthologues (Figure 3.7) 
[179], consistent with observations that this internal deletion in Drosophila Ubx does not 
significantly disrupt the remaining Ubx structure.  The C-terminal disordered region 
(Region 4) spans an alternatively spliced region of Ubx.  The natural Ubx isoform 
UbxIVa removes nearly all (90%) of the intrinsic disorder in this region, and was used to 
assess the contribution of Region 4 to protein interactions. 
Figure 3.7 AkUbx, a Ubx orthologue with only one intrinsically 
disordered region, cannot bind Drosophila Ubx partners.  Sequence alignment 
between Akanthokara kaputensis Ubx (AkUbx) and Drosophila melanogaster 
Ubx showing the locations of disordered residues (red boxes) and the three 
disordered regions (blue labels).   
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Because Ubx is fused to the LexA DNA-binding domain in the yeast two-hybrid 
assay, the transcription activation domain in Ubx was deactivated in each mutant to 
prevent the LexA-Ubx fusion from activating the reporter gene and generating false 
positive signals.  This deactivation was accomplished either by removing a critical 
portion of the activation domain (amino acids 103-216) or by including the mutations 
A226P/Q233P, abbreviated as “Pro4”, to unfold a putative -helix required for 
transcription activation [134].  None of the Ubx variants in this study were able to 
activate transcription on their own, or bind products of the empty bait vector pB42 
(Figure 3.8).  Furthermore, the expression levels of all Ubx variants in yeast were 
similar, except the two Ubx fusion proteins in which the DNA-binding homeodomain 
was replaced with mCherry, which were expressed at much higher levels (Figure 3.9). 
Figure 3.8 Ubx variants did not interact with B42 protein activation in the absence 
of Ubx partners.  Yeast two-hybrid results for wild type full length Ubx or Ubx variants 
with truncation and/or Pro4 mutation showed no significant interaction with B42 protein 
activation domain from β-galactosidase reporter gene expression, listed as Miller Units.     
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Figure 3.9 Ubx variants expression level does not correspond with partner 
interaction strength. (A)  Quantitative Western blotting result for Ubx variants 
protein expression in yeast (Strain:EGY48 transformed with p8op-LacZ reporter 
plasmid).  (B) Weak correlation between yeast two-hybrid result and Ubx variants 
protein expression without outliers (R
2
=0.1403).   Inset plot shows the influence of 
the two outliers (UbxIbN103 Pro4 Δ292-389 mCherry and UbxIb Δ292-389 Pro4 
mCherry) on the correlation between yeast two-hybrid result and the Ubx variants 
protein expression. 
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To clarify which portions of the Ubx sequence are included or removed in each 
variant, the name of each Ubx variant in this text is introduced followed by a notation 
representing the Ubx sequences present in parentheses.  We have divided the Ubx 
sequence into 5 regions (Figure 3.1).  The number representing each region will be 
preceded by an S if the region is structured, a D if the region is disordered, and SD if that 
region contains both structured and disordered elements.  Thus the sequence of full-
length, wild-type Ubx would be depicted as (SD1,D2,S3,D4,S5).  Regions that are 
missing or mutated in a particular variant are designated by 0.  The UbxIb Pro4 mutant, 
in which the helix in region S3 has been destabilized by mutation to prevent 
transcription activation, would be notated as (SD1,D2,0,D4,S5). 
We made a series of Ubx truncations or mutations to sequentially test whether 
each portion of the Ubx sequence contains a critical partner binding site (Figure 3.10).  
All data were compared with UbxIb Pro4 (SD1,D2,0,D4,S5), a full-length variant of 
Ubx which binds all partners but cannot activate the reporter gene in the absence of 
partner interaction.  UbxIb N103 Pro4 (0,D2,0,D4,S5), in which the structured and 
disordered elements in Region 1 were removed, still bound the partner proteins, 
indicating Region 1 is dispensable for partner binding.  UbxIb Δ103-216 
(SD1,0,S3,D4,S5), which removes the intrinsically disordered Region 2, also bound 
some partners.  The previously established ability of UbxIb with the Pro4 mutation 
(SD1,D2,0,D4,S5) to bind partners indicates that the helix in Region 3 cannot be 
responsible for partner binding [132,136].  Conversely, the Pro4 mutations are not 
required for partner binding, because partners bind UbxIb Δ103-216 (SD1,0,S3,D4,S5), 
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which retains the wild-type helix sequence in Region 3.  UbxIVa Pro4 (SD1,D2,0,0,S5) 
binds partner proteins, even though the disordered Region 4 has been removed.  Finally 
we created UbxIb Δ292-389 Pro4 mCherry (SD1,D2,0,D4,0), in which the structured C-
terminus (Region 5) has been removed and replaced with the mCherry protein sequence.  
mCherry alone is unable to bind any of the Ubx partners (data not shown).  However, 
UbxIb Δ292-389 Pro4 mCherry bound all partners, indicating that Region 5, which 
includes the DNA-binding homeodomain, is not necessary for partner binding.  
Collectively, these data indicate that more than one region of Ubx is required for protein 
interactions. 
Figure 3.10  Partner proteins bind more than one region in Ubx. Yeast two-hybrid 
results for Ubx variants in which each region of Ubx has been sequentially mutated or deleted. 
Each of these variants retain some ability to bind Ubx relative to UbxIbN216 (0,0,S3,D4,S5).  
Partners are grouped based on the fold they have in common. 
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The intrinsically disordered regions in Ubx are necessary for protein interactions  
The next step was to identify some portion of the Ubx protein that is necessary 
for partner binding.  The MORF and ANCHOR algorithms both identify many short 
motifs in the intrinsically disordered regions of Ubx that have the potential to engage in 
protein interactions (Figure 3.1B), suggesting the intrinsically disordered regions may 
be collectively required for partner binding.  In order to test this hypothesis, we 
compared binding by the structured versus disordered halves of the Ubx sequence.  
UbxIVa N216 (0,0,S3,0,S5) lacks all of the intrinsically disordered regions but retains 
two of the three regions containing structure.  This mutant is based on the natural 
UbxIVa mRNA splicing isoform, which removes Region 3, and the N216 truncation, 
which removes Regions 1 and 2 (Figure 3.1D).  The remainder of this Ubx variant is 
almost entirely structured (> 90%).  
Conversely, UbxIb Δ292-389 Pro4 mCherry (SD1,D2,0,D4,0) retains all of the 
disordered regions, but lacks the Region 3 helix and the structured homeodomain in 
Region 5.  UbxIVa N216 (0,0,S3,0,S5), which lacks intrinsically disordered sequences, 
was unable to bind all partner proteins, whereas UbxIb Δ292-389 Pro4 mCherry 
(SD1,D2,0,D4,0), which contains all of the intrinsically disordered sequences, bound all 
partners.  In fact, this variant yielded an even more intense reporter signal than Ubx 
alone.  Much of this elevated signal can be attributed to the increased expression level of 
UbxIb Δ292-389 Pro4 mCherry relative to the Ubx variants lacking mCherry (Figure 
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3.11).  Thus Regions 1, 2, and 4, which include all of the intrinsically disordered regions 
in Ubx, are sufficient for partner binding.  
Figure 3.11 The intrinsically disordered regions in Ubx are necessary for 
protein interactions. Yeast two-hybrid indicates that Ubx variants, either lacking 
all disordered regions (UbxIVa N216) or all structured regions (UbxIb N103 
Δ292-389 Pro4 mCherry), cannot bind partner proteins.  Likewise, AkUbx, a 
primitive Ubx orthologue derived from Acanthokara kaputensis, naturally lacks 
most of the disordered sequences and is also unable to bind partner proteins. 
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One concern is that the structured regions may contribute to binding in the full-
length protein, but are mis-positioned by the absence of the disordered regions in the 
UbxIVaN216 (0,0,S3,0,S5) mutant.  To test the latter possibility, we examined whether 
the Ubx partners could bind an orthologue of Ubx derived from the velvet worm 
Akanthokara kaputensis (AkUbx), an onychorphoran whose last common ancestor with 
Drosophila lived 540 million years ago.  Hox proteins in this ancient organism only have 
very basic molecular functions, which are reflected in the relatively simple and repetitive 
body plan of the animal [21,179].  When expressed in Drosophila, AkUbx can replicate 
some, but not all, of the functions of Drosophila Ubx.  Alignment of the Ubx and 
AkUbx sequences demonstrates that the disordered sequences in Regions 1 and 3 are 
absent in this ancient Ubx orthologue, and roughly half of the disordered sequences in 
Region 2 are missing (Figure 3.7).  In contrast, the homeodomain and much of the 
structured portions of Region 1 are preserved.  Therefore, by testing whether AkUbx can 
bind Ubx partners, we can use a native, folded Ubx orthologue to observe whether the 
loss of most of the intrinsically disordered regions prevents partner interaction.  AkUbx 
showed little to no interaction with Ubx partners in the yeast two-hybrid assay (Figure 
3.11). These results confirm that the disordered regions in Ubx are required for partner 
binding.  Because no individual disordered region is solely responsible for partner 
interactions, we conclude that the intrinsically disordered regions in Ubx must cooperate 
to bind partner proteins.  The requirement of multiple, non-contiguous disordered 
regions for partner interaction has been observed previously for other proteins [89,155]. 
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Either Region 1 or Region 4 is required as a scaffold to position intrinsically disordered 
Ubx sequences  
To try to identify a minimal region of Ubx required for protein interactions, we 
began with UbxIb N103 Pro4 (0,D2,0,D4,S5), a truncated variant which binds all partner 
proteins, and iteratively removed each remaining structured or disordered region (Figure 
3.12A). UbxIb N216 (0,0,S3,D4,S5), which additionally removes the disordered Region 
2, cannot bind any of the Ubx partners.  Likewise, UbxIVa N103 Pro4 (0,D2,0,0,S5) 
which removes the disordered Region 4, cannot bind any of the Ubx partners.  Finally, 
the structured C-terminus was removed in UbxIb N103 Δ292-389 Pro4 
mCherry(0,D2,0,D4,0), which also cannot bind Ubx partners.  Therefore Regions 2, 4, 
and 5 can be considered a minimal partner interaction region.  
These data apparently conflict with data from the UbxIb Δ292-389 Pro4 mCherry 
(SD1,D2,0,D4,0) mutant, which also is able to bind all partners but lacks the S5 region 
in the minimal partner interaction region described above.  Instead, this variant includes 
the SD1 region with mixed structure and disorder.  Removal of the SD1 region to create 
UbxIb N103 Δ292-389 Pro4 mCherry (0,D2,0,D4,0) prevents binding to Ubx partners 
(Figure 3.12B).  Therefore the UbxIb Δ292-389 Pro4 mCherry (SD1,D2,0,D4,0) variant 
constitutes a second minimal partner interaction region.  The presence of two minimal 
partner interaction regions that are compatible with many Ubx-binding proteins may 
provide an opportunity for multiple partners to simultaneously bind Ubx.  Inclusion of 
multiple binding sites has been observed for other disordered proteins [132].  The fact 
that both minimal partner binding regions are mainly composed of intrinsically 
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disordered sequences highlights the important role that disorder plays in interactions 
mediated by Ubx. 
Figure 3.12 Defining minimal partner interaction domains. Analysis of yeast two-
hybrid data using Ubx variants identifies two overlapping minimal partner interaction 
domains: UbxIb N103 Pro4 (0,D2,0,D4,S5) (Panel A) and UbxIb Δ292-389 Pro4 mCherry 
(SD1,D2,0,D4,0).  Both minimal partner binding domains include the disordered Regions 2 
and 4. 
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 The intrinsically disordered regions in Ubx differentially contribute to partner binding  
Although the disordered regions are required for partner binding, different Ubx 
partner proteins may best interact with a subset of the Ubx disordered domains.  If so, 
then identifying which intrinsically disordered region within Ubx is preferred by partner 
proteins could provide clues regarding the functional outcome of each partner 
interaction.  For example, a partner that bound the Ubx transcription activation domain 
might alter the balance between transcription activation and repression by Ubx  [78].  
Although the experiments described above suggest that the disordered regions 
are necessary for binding, they do not reveal which of the disordered regions are bound 
by partners.  The most straightforward approach is to compare a Ubx variant with no 
disordered regions (UbxIVa N216) with a variant which includes just one of the 
disordered regions (Region 1, UbxIVa Δ103-216 (SD1,0,S3,0,S5); Region 2, UbxIVa 
N103 Pro4 (0,D2,0,0,S5); Region 4, UbxIb N216 (0,0,S3,D4,S5).  However, little to no 
partner binding was observed for all three of these variants, indicating more than one 
disordered region must be present for any partner to bind, consistent with the 
identification of the minimal binding regions described above (Figure 3.13). 
To test the strength of different cooperative units, we compared variants missing 
each of the three disordered regions in turn (Region 1 deleted, UbxIb N103 Pro4 
(0,D2,S3,D4,S5); Region 2 deleted, UbxIb Δ103-216 (SD1,0,S3,D4,S5); Region 4 
deleted, UbxIVa Pro4 (SD1,D2,S3,0,S5).  As already discussed, each of these mutants is 
still able to bind Ubx partner proteins.  However, partner affinity is reduced to different 
extents (Figure 3.10).  Binding by 14-3-3, RpL22, Apt, and Dsh was equally affected 
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by removing Regions 1, 2, or 3.  Since a large percentage (≥ 59%) of the signal was lost 
in each of these interactions, an interesting interpretation is that these proteins may 
simultaneously bind all three regions.  For other partners, the magnitude of the reduction 
in protein interaction varies for the three regions. Whereas removing Regions 1 and 3 
had a significant effect on binding all partners, for a subset of partners (e.g., p120ctn, Al, 
and CBP80), removing Region 2 had less impact.  The ability of these three variants to 
bind partner proteins does not appear to correlate with the topology of the partner. 
Figure 3.13 Ubx-interacting proteins cooperatively bind Regions 1, 2, and 
3, all of which contain intrinsically disordered sequences.  No single Ubx 
disordered region is sufficient to support partner binding, suggesting multiple 
disordered regions function as a cooperative unit.   
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Partners differentially interact with alternatively spliced isoforms of Ubx 
Binding by all partners relies to some extent on contacts with Region 4, which 
contains sequences included in or excluded from Ubx by alternative mRNA splicing.  
Expression of Ubx splicing isoforms is regulated in a stage- and tissue-specific manner 
during Drosophila embryonic development [180].  Ubx  isoforms are generated through 
differential inclusion of three different microexons in ubx mRNA, all of which code for 
protein sequences within Region 3: the b element, microexon I, and microexon II 
(Figure 3.1).  Expression of these three splice variants elicits different phenotypes in 
vivo  [2,88].  To determine the impact of alternative splicing on partner interactions, we 
compared the ability of UbxIb Pro4 (containing all three microexons), UbxIa Pro4 
(containing the mI and mII microexons) and UbxIVa Pro4 (containing no microexons) to 
bind partner proteins.  
Removal of all three microexons in the UbxIVa Pro4 variant reduces the ability 
of Ubx to bind all partners relative to UbxIb Pro4 (Figure 3.14A).  This reduction ranges 
from 85% (CBP80) to 60% of binding lost (Arm).  For some partners (RpL22, Apt, and 
Dsh), removal of only the 9-amino acid b element altered binding to the same extent as 
removing all three microexons, indicating these interactions are critically dependent on 
the presence of the b element.  We cannot discern from these experiments whether the b 
element contributes key chemical groups required for interaction or simply lengthens the 
intrinsically disordered region to generate a sufficiently large binding interface.  Partner 
affinity has also been linked to the dynamics of the disordered region [181].  
Intriguingly, disorder prediction algorithms yield very different scores for different Ubx 
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Figure 3.14 Partner topology determines Ubx splicing isoforms are 
differentially able to bind partner proteins which correlate with the predicted 
disorder profile of isoforms. (A) Whereas all partners with an - superhelix 
fold bind UbxIa better than UbxIVa, among partners with a DNA/RNA binding 
3-helical bundle fold only Al binds these two Ubx isoforms differently.  “Inc” 
denotes Region 3, the microexon region, and is incomplete in the UbxIa splicing 
isoform.  The disordered regions remaining in each variant are listed in 
parentheses after the protein name. (B) Colored lines represent intrinsic disorder 
prediction scores for the microexon region for different Ubx splicing isoforms, 
generated using the PONDR VL-XT algorithm [182].  Blue line, UbxIb which 
has all 3 microexons; grey line, UbxIa which lacks the 9 amino acid b element; 
red line, UbxIVa, which lacks all 3 microexons.  Dashed lines connect data 
across the microexon sequences removed in the shorter isoforms.  The extent of 
predicted disorder (score >0.6, region shaded light grey) correlates with the 
ability to bind the tested partner proteins. 
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splicing isoforms (Figure 3.14B).  These differences suggest that Ubx dynamics may 
influence Ubx-partner binding. 
Partner topology generally correlates with partner affinity for different Ubx 
splicing isoforms.  All proteins with an α-α superhelix fold bind UbxIa better than 
UbxIVa, whereas all but one protein (Al) with a DNA/RNA binding 3-helical bundle 
fold bind UbxIa and UbxIVa equally well (Figure 3.14A). This correlation reflects 
similarities in binding by partners with the same fold.  Interestingly, the Eukaryotic 
Linear Motif (ELM) prediction algorithm revealed a 14-3-3ε binding motif in the mII 
microexon sequence [183-185], which may explain why 14-3-3ε binds UbxIa Pro4, but 
not UbxIVa Pro4, which is missing this motif.  In general, the proteins with a strong 
isoform effect (UbxIb > UbxIa > UbxIVa) were all negatively charged (14-3-
Arm, CBP80, p120ctn, and Rpn6), perhaps due to the position of the alternatively 
spliced microexons adjacent to the positively charged homeodomain.  The previously 
characterized Ubx partner, Exd, also has a net negative charge and differentially binds 
Ubx isoforms [79].  Proteins that bind UbxIa and UbxIVa equally well can be either 
positively or negatively charged.  Thus, although all partners bind disordered regions, 
the topology and charge of the partner protein correlate with their ability to bind 
different Ubx isoforms.  Differences in the affinity of partners for Ubx isoforms create 
the potential for ubx mRNA splicing to regulate Ubx-partner interactions in vivo. 
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Discussion 
We have demonstrated that partner topology is a key aspect of protein 
interactions formed by the intrinsically disordered regions of the Drosophila Hox protein 
Ubx.  Greater than 60% of Ubx-binding proteins have a fold in common with at least one 
other Ubx partner, and Ubx binds the selected fold within these proteins.  Other 
laboratories have also identified disordered proteins that bind multiple partner proteins 
with similar structures [157,186].  These partners were related proteins from the same 
protein family.  In contrast, Ubx binds structurally similar, yet widely diverse proteins 
with very different chemical natures and molecular functions.  Binding multiple partners 
with similar structures may reduce frustration in the Ubx-partner interface compared to  
interactions disordered proteins and an array of partner topologies [83].  
A model for the role of structure in Ubx-partner binding  
Many proteins that interact with intrinsically disordered proteins or regions bind 
a MORF, a short motif within a disordered region of a protein that often folds upon 
partner binding.  In the case of Ubx, three large disordered regions all simultaneously 
contribute to partner binding.  The fact that the topology of the partner protein is 
important suggests that the disordered regions may need to be positioned in a specific 
manner in order to maximize interactions with the partner protein.  This model fits with 
our data on the role of Regions 1 (partially structured) and 5 (structured) in partner 
binding. Structure-containing region is not sufficient for partner binding and partner 
binding can occur in the absence of either region.  The inability of AkUbx, a natural Ubx 
orthologue which lacks most of the disordered regions, to bind partners demonstrates 
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that the lack of binding is not an artifact induced by mis-positioning structured regions in 
Ubx mutants.  However, either Region 1 or Region 5 must be present for the disordered 
regions in Ubx to bind partner proteins, suggesting either of these regions can correctly 
position the disordered domains for partner binding.  This positioning may involve 
binding the disordered regions: the Ubx homeodomain, which is located in Region 5, has 
a DNA/RNA-binding 3-helix bundle fold, one of the two major folds selected by Ubx.  
The intrinsically disordered regions of Ubx directly interact with the homeodomain to 
alter its DNA binding affinity and specificity and with each other to enable cooperative 
DNA binding in vivo and materials formation in vitro [124,187].  
Implications for Ubx function  
The identification of partner-binding regions within Ubx, and the overlap of 
these regions with each other and with known functions or regulatory mechanisms, has 
important implications for regulating tissue-specific Ubx function in vivo. Whereas some 
partners bind all three regions to an equal extent (14-3-3ε, RpL22, Apt, and Dsh), other 
partners depend more heavily on Regions 1 and 3 for binding to Ubx (Arm, 
p120ctn,CBP80, and Al).  Ubx partners reliant on the same regions of Ubx for binding 
may compete for binding to these regions. For partners that bind equally well to all three 
intrinsically disordered regions, the long length of these regions, may enable more than 
one partner to simultaneously bind Ubx.  Indeed, other proteins with long disordered 
regions can act as a scaffold to simultaneously bind multiple partner proteins and create 
multi-functional complexes [188,189].  In the context of transcription regulation, using 
Ubx as a scaffold for constructing a multi-protein transcription factor complex allows 
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Ubx-mediated transcription regulation to respond to input from multiple protein systems 
[70].  The correct, tissue-specific regulatory complex would be stabilized by Ubx-DNA 
interaction, partner-DNA interactions, and partner-Ubx interactions. 
All Ubx partners rely, to some extent, on Region 2 for binding.  Since Region 2 
includes critical sequences for transcription activation by Ubx [134], partner binding 
may modulate the ability of Ubx to activate transcription.  Further, multiple 
phosphorylation sites exist within Regions 1 and 2 [190], suggesting that 
phosphorylation of this region in vivo has the potential to regulate Ubx activity by 
removing bound proteins, stabilizing protein interactions, and / or altering which 
proteins are bound to this region. Alternative splicing alters the ability of Ubx to bind 
partners, a regulatory mechanism used to regulate the other protein interactions [191].  
Alternative splicing, combined with protein partner availability may also impact how 
Ubx selects DNA binding sites.  Ubx binds three different categories of DNA sequences, 
defined by the protein interactions in which Ubx engages: i) multiple, closely spaced 
Hox binding sites that permit cooperative Ubx binding, ii) single or multiple Hox 
binding sites interspersed with binding sites for other transcription factors, or iii) Hox-
Exd heterodimer binding sites (Figure 3.15).  The partner binding preferences of each 
Ubx isoform, combined with the presence or absence of partners in the tissues in which 
that isoform is expressed, could determine which subset of DNA sequences are regulated 
by Ubx in each tissue.  For example, the presence of the b element enhances binding by 
the partners examined in this study, but reduces binding by Exd, the general Hox 
cofactor in Drosophila.  Thus, we would predict that UbxIa would preferentially bind 
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Figure 3.15  Ubx recognizes three categories of DNA binding sites.  Ubx 
cooperatively binds multimers of Hox binding sites (TAAT/ATTA, red text), including 
enhancers for the ubx and antp genes [83].  Other transcription factors are not known to 
influence Ubx binding to these sites.  In the second category, DNA binding sites for Ubx 
monomers are separated by DNA binding sites for other transcription factors (Medea, 
purple text, and Mad, green text) [60].  Regulation of the sal gene is coordinated by both 
Ubx and BMP signaling, which controls the activity of Medea and Mad.  In the final 
category, Ubx binds DNA and regulates transcription in association with Exd (blue text) 
and Hth (orange text), general Hox co-factors [192,193].  The positions of the DNA 
sequences are marked in bp relative to the start of transcription. 
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Exd, and hence Hox-Exd heterodimer DNA binding sites, whereas UbxIb would 
preferentially interact with other transcription factors to regulate DNA sequences in 
which Ubx binding sites are interspersed with partner binding sites.  Because these 
isoforms are expressed in the same tissues but not at the same levels [194], the relative 
concentrations of UbxIb and UbxIa may partition the available Ubx protein between 
genes regulated by Ubx-Exd heterodimers relative to genes regulated by Ubx in 
conjunction with other partner proteins.  Likewise, the absence of partner proteins or the 
decreased affinity of partner proteins for a particular Ubx isoform, may direct Ubx to 
cooperatively bind DNA as homo-oligomers.  Together, these mechanisms may 
contribute to isoform-specific differences in target gene recognition in vivo [2,88,195].  
Finally, whereas the α-α superhelix partners bound specific disordered regions 
and Ubx isoforms better than others, the DNA/RNA binding 3-helical bundle fold 
partners tended to bind all three disordered regions equally well and bound UbxIa as 
well as UbxIVa.  The reduced sequence specificity of DNA/RNA binding 3-helical 
proteins may reflect the fact that all of the disordered regions in Ubx evolved to interact 
with the Ubx homeodomain to regulate DNA binding [65,66].  Since the homeodomain 
has a DNA/RNA binding 3-helical fold, the homeodomain-interacting disordered 
regions can also bind other proteins with this same fold.  This hypothesis predicts that 
protein interactions may enhance DNA binding by removing the inhibitory disordered 
regions from the surface of the Ubx homeodomain.  Conversely, DNA binding may 
facilitate Ubx-partner interactions by making the disordered regions more available for 
partner interactions.  This scenario provides a mechanism, consistent with its cellular 
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role, for Ubx to functionally integrate binding to a multiplicity of diverse protein 
partners and to DNA. 
The sequence of intrinsically disordered regions evolves more rapidly than for 
structured regions [196,197], enabling incorporation of novel functions or binding 
modes.  Indeed, the evolution of novel protein interaction motifs can change Hox 
function [179] or even dramatically transform a Hox protein into to a different class of 
transcription factor [198].  Based on our current knowledge, Ubx appears unlikely to 
interact with a subset of the proteins identified as binding partners for its natural in vivo 
function [132].  However, the ability of Ubx to bind functionally different proteins with 
similar structures may provide a mechanism to evolve novel Ubx functions.  A new 
protein may be able to bind the disordered regions in Ubx based on its resemblance to an 
established Ubx partner, creating new modes of Ubx (or partner) regulation in vivo.  As 
the Ubx sequence evolves, a specific motif for binding that partner may emerge, and 
with time eventually become an obligatory binding site.  Examples of proteins at each of 
these stages may be found among the Ubx partner proteins.  Most of the partners appear 
to recognize the disordered regions without any clear sequence or motif preferences, 
representing a relatively early stage in the evolution of partner binding.  However, a 14-
3-3ε interaction motif occurs in the mII element of Ubx [183-185].  Although the 
presence of this motif enhances 14-3-3ε binding, this protein still binds Ubx, albeit 
weakly, in the absence of this motif.  Furthermore, the motif is located in a region of the 
Ubx protein for which inclusion depends on ubx mRNA splicing, allowing tissue-
specific control of Ubx’s affinity for 14-3-3ε. 
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Evolution of Hox function  
  In our model, the enhancement, but not obligatory reliance, of partner binding 
by a recognition motif represents an intermediate stage of partner evolution.  Finally, 
Exd/Pbx is an ancient Hox protein partner required for many basic Hox functions.  
Although the disordered regions in Ubx influence Exd binding, Exd interactions are 
primarily dependent on specific motifs in the Ubx sequence [197].  Exd binds different 
motifs in Ubx to elicit different functional outcomes in vivo [199].  Thus Ubx-Exd 
interactions represent a highly evolved partner interaction.   
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CHAPTER IV  
CELL BEHAVIOR STUDY IN 3D MODEL USING SELF-ASSEMBLE UBX 
PROTEIN MATERIALS 
 
Introduction 
Because cell culture is versatile, rapid, and cost-effective, it has been widely used 
for basic research and preclinical studies. Most cells are cultured systems on a 2-
dimensional (2D) surface such as tissue culture flask, however, the in vivo environment 
is composed of 3-dimensional (3D) elements [200,201]. Indeed, cells often react 
differently in 3D and 2D culture systems [202-204]. With similar but more aggressive 
cellular cycle, cancer cells often show different responses between 2D and 3D culture 
including gene expression, proteolysis, and drug resistance [116,205,206]. For instance, 
expression of matrix metalloproteases (MMPs) was upregulated in 3D scaffolds 
compared with 2D flat surface culture with the same materials [207]. In addition, 
previous studies have shown that cancer cells are more resistant to anticancer drugs on a 
3D substrate surface than a 2D substrate surface [208-211].  
A variety of natural and chemically synthesized materials have been adopted 
from tissue engineering purpose to establish 3D cancer cell culture models in vitro [212-
215]. The essential quality for materials suitable for tissue engineering purpose are also 
advantages in cancer cell cultures such as: robotic production, inert interactions with 
cells, appropriate properties and physical support to cells, and adjustable properties for 
various experimental designs [216].  However, few materials have been able to 
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accommodate these properties without significant compromise. For example, synthetic 
materials often lack cell binding moieties on the material surfaces and nature-derived 
materials often required sophisticated procedures for production and adjustable 
properties for various tasks [217].     
In vivo, the Drosophila melanogaster Ultrabithorax (Ubx) protein functions as a 
transcription factor [57,218]. In vitro, monomeric Ubx protein self-assembles into  
nanoscale to microscale materials [124,219]. Importantly, Ubx materials are 
cytocompatible, biocompatible, and non-immunogenic [126,127]. Cells readily adhere to 
Ubx materials, which can serve as a substrate for cell cultures. In this study, we tested 
the compatibility between Ubx materials and three different isogenic human breast cell 
lines including MCF10A, MCF10AT, and MCF10CA-1a. The MCF10A cell line was 
derived from benign breast tissue from a woman with fibrocystic disease [220]. The 
premalignant MCF10 AT cell line, generated from T24 c-Ha-ras oncogene-transfected 
MCF10A cells, has a tendency for neoplastic progression [221]. The metastatic 
MCF10CA-1a cell line was derived from MCF10AT cells mouse xenografts [222].  
Because MCF10A cell lines are isogenic, they provide a valuable opportunity for 
determining how tumorigenesis impact cell behavior in a 3D environment. We found 
that all MCF10A cell lines, either normal mammary gland cells (MCF10A), semi-
tumorigenic cells (MCF10AT) or tumorigenic cells (MCF10CA-1a), survive on Ubx 
materials at various time points. Most interestingly, we also observed massive 
destruction of Ubx materials by MCF10CA-1a cell line but not MCF10A or MCF10AT. 
The possible mechanism behind the MCF10CA-1a specific Ubx materials destruction 
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was also investigated in this study. Differences in cytoskeleton structure between 
different cell types on a 2D surface and on 3D Ubx materials were also recorded. Our 
results indicate that Ubx materials have the potential for establishing in vitro 3D cell 
culture for cancer study.   
 
Materials and Methods 
Ubx Ia protein expression and purification 
His-tagged Ubx Ia protein was expressed as previously described [124-127]. In 
brief, the plasmid, constructed in the pET19b expression vector and Ubx Ia cDNA, was 
transformed into BL21(DE3)-pLysS strain of E.coli (EMD Millipore). Ubx Ia protein 
expression was induced by adding 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG, 
RPI) at the log phase of growth. The E.coli was allowed to express the protein at 25 °C 
for 2 hours with shaking at 250 rpm. Cells were harvested by centrifuged at 1,200 x g at 
4 °C. Cell pellets, in aliquots corresponding to 2 L of bacterial culture, were stored at -
20°C in 5 ml of PBS buffer. A frozen cell pellet was lysed in 15 mL of lysis buffer 
(Buffer G) containing 50 mM NaH2PO4 (pH = 8.0), 5% glucose (w/v),  and 500 mM 
NaCl. In addition, one ethylenediaminetetraacetic acid-free protease inhibitor tablet 
(Roche) and 1.2 mg/L DNase I were included to prevent proteolysis of monomeric Ubx 
proteins and facilitated the digestion of  DNA in the cell lysates, respectively. After 
centrifuging for 30 minutes at 4°C, the supernatant was incubated with Ni-NTA resin 
(Thermal Scientific) pre-equilibrated with Buffer G for 15 minutes. The column was 
iteratively washed with Buffer G containing 20mM, 40mM, and 80mM imidazole 
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followed by the elution using Buffer G containing 200mM imidazole. The purified 
monomeric Ubx Ia proteins were stored 4°C until Ubx fiber production. 
Production of Ubx fibers and bundles  
Ubx Ia protein fibers were produced using the tray / buffer reservoir system 
[124,125]. To create Ubx bundles, inoculation loops were flattened with a hammer and 
subsequently wrapped in recently fibers immediately after drawing the fibers from a 
tray.  Buffer G was applied to the inoculation loops to cover the with Ubx fibers with a 
thin film of buffer. Buffer G was removed slowly by pipetting from the area between the 
Ubx fibers and the inside edge of inoculation loops, thus forcing the Ubx fibers into 
contact, forming Ubx bundles. The Ubx bundles were dried in a biohazard hood before 
placement onto the chamber slide.  
Cell culture  
MCF10A and MCF10AT were cultured in sterile DMEM/F12 media containing 
0.12 % sodium bicarbonate (w/v) (Sigma), 5 %  heat inactivated fetal bovine serum 
(w/v) (Gibco), 10 µg/ml insulin (Sigma), 20 ng/ml epidermal growth factor (Gibco), 0.5 
µg/ml hydrocortisone (Life technologies), 15 mM of  4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, Caisson), and 17.5 mM glucose with pH = 7.4 
and 5% CO2 at 37 °C. MCF10CA-1a cells were cultured in DMEM/F12 media 
containing 0.12% sodium bicarbonate (w/v), 10% of horse bovine serum (w/v) (Gibco), 
15 mM HEPES (Caisson), and 17.5 mM glucose with pH = 7.4, 5 % CO2 at 37 °C. Cells 
were cultured to confluence then 20000 - 30000 cells per well were seeded in chamber 
slides (Ibidi) to maintain consistent confluence for each experiment. Inoculation loops, 
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each wrapped multiple times with a single Ubx fiber, were placed in separate wells on 
the chamber slide together with the cells. Sample wells for immunostaining were fixed 
with paraformaldehyde (4 % w/v) at designated time points.  
Immunochemistry experiments  
A freshly made 8% paraformaldehyde (w/v) stock in phosphate-buffered saline 
(PBS) was added to the existing culture media at a final concentration of 4%, and 
samples were fixed at room temperature for 2 hours in a chamber slide (Ibid). Fixed 
samples were washed three times for 10 minutes with 200 µl wash buffer 1 (25 mM Tris, 
200 mM glycine). Samples were permeablized with 200 µl of  Dulbecco's phosphate-
buffered saline (DPBS, Life technologies), containing 0.5% Triton X-100 (Sigma), for 
20 minutes at room temperature. Wells were aspirated and blocked at room temperature 
in 300 µl of blocking solution containing 0.1% Triton X-100, 1% BSA, and 5% goat 
serum for 1 hour. Primary antibodies raised against α-tubulin (Sigma) were diluted 1:50 
in blocking solution and incubated in the wells for 1 hour at room temperature. Samples 
were washed 3 times for 10 minutes each in 200 µl of wash buffer 2 containing 0.1% 
Triton X-100 in DPBS and incubated with (1:200 dilution) goat anti-mouse Alexa 488 
conjugated secondary antibodies (Life technologies) in blocking solution for 30 minutes 
at room temperature. Samples were washed 3 times in 300 µl DPBS containing 0.1% 
Triton X-100, 10 µM 40, 6-diamidino-2-phenylindole (DAPI, Molecular Probes) for 10 
minutes and imaged immediately using confocal microscopy on a Nikon Eclipse Ti 
equipped with NIS Elements AR 4.10.01 software. 
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Live/dead cell viability assay 
After incubation with Ubx fibers for the designated duration specified, the media 
was removed by vacuum and the wells were rinsed 6 times with 200 µl of DPBS 
containing 0.05 mM Mn
2+
 and 0.5 mM Mg
2+
  to remove excess serum in the media. 
DPBS solution containing 2 µM calcein acetoxymethylester and 4 µM ethidium 
homodimer-1 (Live /dead cell viability assay kit, Molecular Probes) was later added into 
the wells for cell staining. The live/dead cell viability assay reagents were incubated 
with cells for 10 minutes at room temperature and imaged using confocal and fluorescent 
microscopy on a Nikon Eclipse Ti equipped with NIS Elements AR 4.10.01 software. 
Images were taken in differential interference contrast (DIC) format or fluorescent 
format.  
Proteolysis inhibition assay 
MCF10CA-1a cells were seeded in a chamber slides together with 20000 
cells/well in a chamber slide (Ibidi) with in medium in a final volume of 200 µl/well. A 
broad spectrum matrix metalloproteinase (MMP) inhibitor, GM6001, (Santa Cruz  
Biotechnology) was added into the medium to under a serial dilution 12 µM to 120 nM 
at the final concentration according to manufacturer recommendation to determine the 
optimal concentration. The final concentration of 12 µM was used in this study 
according to the results from serial dilutions. The total number of Ubx fibers was 
recorded immediately after the initial seeding the MCF10CA-1a cells. An individual 
Ubx fiber with the connection between two attaching points on individual inoculation 
loop is considered an intact fiber and vice versa. The percentage of intact Ubx fibers at a 
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designated time point versus total the number of intact Ubx fibers at the initial time point 
was calculated. 
 
Results 
Ubx fibers are compatible with MCF10A cells 
In order to establish a sustainable 3D culture, the materials used for composing 
the scaffolds should not have any toxicity to cells. Previous study in our laboratory has 
shown that plain Ubx and mCherry-Ubx protein fusion materials are compatible with 
three different primary human cell lines including: umbilical vein ECs, brain vascular 
PCs, and aortic SMCs [126]. However it is not clear if Ubx materials will be toxic to 
mammary gland cells since there is an anti-tumorigenic sequence in the conserved 
homeodomain of Ubx [223-225]. In order to monitor the progression of the viability of 
the cells, we treated the cells with live/dead cell viability assay after cell incubated with 
Ubx fibers at various time points. No evidence of cell death was observed when 
MCF10A cells when incubated with Ubx fibers at various time points (Figure 4.1), 
either in close proximity to Ubx fibers (<10 µm), or far from Ubx fibers (>100 µm ) at 
24 hours and 48 hours (Figure 4.1B-C, 4.1E-F, 4.1H-I, 4.1K-L). Both experimental 
groups showed over 97% survival rate. Therefore, Ubx materials are not toxic to these 
cells and they do not secret toxic substances into the media. Increased cell density of 
MCF10A cells on Ubx fibers at 12 hours after the initial seeding compared to 6 hours as 
observed (Figure 4.1B-C, 4.1E-F). MCF10A cells attached to Ubx fiber with orientation  
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Figure 4.1 Ubx fibers are not toxic to MCF10A cells. DIC images were 
taken before live/dead staining at 6 (A), 12 (D), 24 (G), and 48 (J) hours, 
respectively, to show the relative position of Ubx fibers and cell population at 
different time points. Live/dead cell viability assays were performed to show 
the viability of MCF10A cells at 6 (B-C),12(E-F), 24(H-I), and 48 hours (K-
L), respectively. Red arrows indicate Ubx fibers and live MCF10A cells are 
shown in green. The white dashed rectangular indicates area enlarged 2X for 
images with higher magnification. Scale bars equal 10 µm in panel C, F, I, 
and L. Scale bars equal 100 µm in all other panels.  
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aligned with the axis of Ubx fibers at 24 hours after the initial seeding (Figure 4.1I-L).  
High density of MCF10A cells settled on Ubx fibers. Most notably, most 
MCF10A cells attached to both the top and sides of Ubx fibers. If MCF10A cells were 
forced to attach to Ubx fibers, attachment of the cell will only be seen at certain area and 
not in all dimensions of Ubx fibers. Our results indicate the self-motivated attachment to 
Ubx fibers from MCF10A cells instead of forced attachment during cell seeding. 
Ubx materials are compatible with MCF10AT cells 
Among MCF10A isogenic cell lines, MCF10AT cell was considered semi-tumorigenic 
due to the fact that 25% of  MCF10AT cells will become malignant cells after prolonged 
culture and selection  [221]. Due to the undetermined cell fate of MCF10AT cells, it will 
be useful to see the cellular responses of MCF10AT to Ubx materials for a 
comprehensive view of the progression in tumorigenesis. MCF10AT cells were seeded 
in a chamber slide containing designated medium and Ubx fibers.  Cell viability was 
determined by staining the cells with live/dead cell viability assay and visualized using 
confocal and fluorescent microscopy at 6 hours, 12 hours, 24 hours, and 48 hours. 
Similar cellular responses as MCF10A cells were also observed from MCF10AT cells 
on Ubx fibers (Figure 4.2). MCF10AT cells did not show signs of cell death when 
incubated with Ubx fibers neither at shorter time points such as 6 hours (Figure 4.2B, 
4.2C) and 12 hours (Figure 4.2E, 4.2F), nor at longer time points  such as 24 hours 
(Figure 4.2H, 4.2I) and 48 hours (Figure 4.2K, 4.2L) . The average survival rate was 
over 98% on the Ubx fibers and cells in the same well on the bottom of chamber slide  
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Figure 4.2 Ubx fibers are not toxic to MCF10AT cells for 
prolonged incubation. DIC images were taken before live/dead staining 
at 6 (A), 12 (D), 24 (G), and 48 (J) hours, respectively to show the 
relative position of Ubx fibers and cell population at different time 
points. Live/dead cell viability assays were performed to show the 
viability of cells at 6 (B-C), 12(E-F), 24(H-I), and 48 hours (K-L), 
respectively. Red arrows indicate Ubx fibers and live MCF10AT cells 
are shown in green. The white dashed rectangular indicates area 
enlarged 2X for images with higher magnification. Scale bars equal 10 
µm in panel C, F, I, and L. Scale bars equal 100 µm in all other panels.  
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across all time points. There were more MCF10AT cells attached on Ubx fibers at longer 
time points then shorter time points (Figure 4.2).  MCF10AT cells were also located on 
both the top and sides of Ubx fibers.  Although, MCF10AT cells were aligned to the axis 
of Ubx fibers but MCF10AT cells showed more spindle type of morphology, which was 
different from MCF10A cells on Ubx fibers.    
Ubx materials are compatible with MCF10CA-1a cells 
Previous experiments have shown the cytocompatibility of Ubx fibers to both 
MCF10A and MCF10AT, which represent normal and semi-tumorigenic mammary 
gland cell, respectively, in the whole spectrum of MCF10A isogenic cell lines. Next, we 
tested the compatibility between MCF10CA-1 and Ubx fibers.  There were no 
conclusive signs of cell death on Ubx fibers for MCF10CA-1a cells with direct contact 
or indirect contact with Ubx fibers at various time points (Figure 4.3). MCF10CA-1a 
cells were alive on Ubx fibers at 48 hours after the initial seeding (Figure 4.3J-L). 
Physical attachment of MCF10CA-1a cells was observed at 6 hours (Figure 4.3A-C). 
MCF10CA-1a cells covered most of the surface on the Ubx fibers at 24 hours (Figure 
4.3G-H, 4.3L). Compared to MCF10A and MCF10AT cells, MCF10CA-1a cells exhibit 
two unusual behaviors: MCF10CA-1a broke Ubx fibers and they have an unusual 
morphology at later time points. Ubx fibers started to rupture at 12 hours (Figure 4.3D-
F) and all Ubx fibers had broken into fragments  with size of 10-20 µm in length by 48 
hours (Figure 4.3J-L) when incubated with MCF10CA-1a. During this study, we 
noticed some correlations between the diameter of Ubx fibers and the time required for 
Ubx fibers to rupture. The working hypothesis was that Ubx fibers with larger diameter  
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Figure 4.3 Ubx fibers are not toxic to MCF10CA-1a cells for prolonged 
incubation. DIC images were taken before live/dead staining at 6 (A), 12 (D), 24 
(G), and 48 (J) hours, respectively to show the relative position and cell population 
at different time points. Live/dead viability assays were performed to show the 
viability of cells at 6 (B-C), 12(E-F), 24(H-I), and 48 hours (K-L), respectively.  
Red arrows indicate Ubx fibers and live MCF10CA-1a cells are shown in green. The 
white dashed rectangular indicates area enlarged 2X for images with higher 
magnification. Scale bars equal 10 µm in panel C, F, I, and L. Scale bars equal 100 
µm in all other panels.  
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required more time to rupture compared with Ubx fibers with smaller diameter. We 
decided to fuse individual Ubx fibers into Ubx bundles [124]. The bundles, with their 
wider diameters, should enhance the durability of Ubx materials in the presence of 
MCF10CA-1a cells (Figure 4.4). As expected, the Ubx bundles were mostly intact until 
later time points (Figure 4.5), which provided the opportunity to qualify the response 
from MCF10CA-1a on Ubx bundles.  The MCF10CA-1a cells started attaching to Ubx 
bundles at 6 hours and into later time points. There were no sign of cell death for cells in 
the contact with Ubx bundles at all of time points neither those cells surrounding Ubx 
bundles without direct contact. 
 
 
 
Figure 4.4 Ubx bundle production process. (A) Ubx fibers (black lines) were 
attached to the plastic loop (grey oval shape object). Buffer G (area with grey gradient) 
was applied on the plastic loop with Ubx fibers using pipette (grey triangle). (B) 
Buffer G was removed by pipetting on both sides of Ubx fibers to create surface 
tension between the two Ubx fibers. (C) Several Ubx fibers were bound as a bundle 
after the removal of Buffer G. 
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Figure 4.5 Ubx bundles can accommodate MCF10CA-1a cells for 
prolonged incubation. (A, D, G, J) The relative locations on Ubx bundles 
for confocal images are indicated by black dashed rectangular. DIC images 
of MCF10CA-1a cells with live/dead staining at 6 (B), 12 (E), 24 (H), and 
48 (K) hours after the initial seeding, respectively, show the relative 
position and cell population at different time points. Live/dead viability 
assays were performed to show the viability of cells at 6 (C), 12(F), 24(I), 
and 48 hours (L), respectively. Red arrows represent Ubx bundles. Scale 
bars equal 100 µm in all panels. 
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Matrix metalloproteinases (MMPs) inhibitor prevents MCF10CA-1a specific Ubx 
materials destruction  
The destruction of Ubx fibers and Ubx bundles by MCF10CA-1a cells triggered 
us to probe the possible mechanisms behind the phenomena. We compared all the 
images taken at different time points from three different cell lines tested in this study.  
We have found that only MCF10CA-1a cells are capable of breaking Ubx fibers, 
regardless the size of the fiber (Figure 4.6). At 6 hours, individual MCF10CA-1a cells 
were seen at areas where Ubx fibers were partially destroyed (Figure 4.6A-B). 
Live/dead cell viability assays showed that MCF10CA-1a cells extend into the 
cracked regions on Ubx fibers. At 12 hours, Ubx fibers were more damaged in areas 
where MCF10CA-1a cells were situated. In some cases, sections of the Ubx fibers 
appeared to be cut away (Figure 4.6C-D).   
 
 
 
Figure 4.6 Ubx fibers were destructed by MCF10CA-1a cells. (A,C) 
DIC and fluorescence merged images show the topography of Ubx fibers and 
relative location of MCF10CA-1a cells on Ubx fibers. (A-B) MCF10CA-1a 
cells (green) situated at the Ubx fibers (red arrows) at 6 hours after the initial 
seeing. Ubx fibers were partially destructed (red arrows).  (C-D) MCF10CA-1a 
cells (green) situated at the Ubx fibers (red linear structure) at 12 hours after 
the initial seeing. Ubx fibers were increasingly destructed (red arrows). Scale 
bars equal 10 µm in all panels. 
 
 
 95 
 
This damage could potentially be caused by mechanical forces exerted by the 
cells on Ubx materials and/or by proteases secreted by MCF10CA-1a cells. MMPs are 
upregulated in MCF10CA series cells compared with MCT10A [226,227], indicating a 
possible link between the destruction of Ubx fibers and MMPs. Indeed, structural 
integrity of Ubx fibers was preserved at various time points when GM6001, a broad 
spectrum MMP inhibitor, was present in the media at concentrations of 12 µM (Figure 
4.7). 
 
 
 
Figure 4.7 MMPs inhibitor prevents MCF10CA-1a related Ubx materials 
destruction. Time course experiments with broad spectrum MMP inhibitor show 
inhibition of MCF10CA-1a related Ubx fibers destruction. “-ˮ represent data 
collected at different time points (X axis) without the addition of MMPs inhibitor. 
“+ˮ represent data collected at different time points (X axis) under the presence 
of MMPs inhibitor. 
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 It is possible that viability of MCF10CA-1a cells were compromised by 
GM6001. Live/dead cell viability assays were performed and have shown alive 
MCF10CA-1a cells on Ubx fibers under the presence of GM6001 at various time points 
(Figure 4.8). Therefore, the GM60001 did not impede the viability of MCF10CA-1a 
cells in this experiment.    
 
 
 
Figure 4.8 GM6001, a broad spectrum MMPs inhibitor, preserves 
structural integrity of Ubx fibers and do not kill MCF10CA-1a cells. (A, C, E) 
DIC and fluoresce merged images of MC10CA-1a cells (green) and Ubx fibers 
(red arrows). (B, D, F) Fluorescent images show alive MCF10CA-1a cells (green) 
on intact Ubx fibers (red arrows). (A, B) Live MCF10CA-1a cells on intact Ubx 
fibers at 12 hours after the initial seeding in the presence of GM6001. (C, D) 
Live MCF10CA-1a cells on intact Ubx fibers at 24 hours after the initial seeding 
in the presence of GM6001. (E, F) Live MCF10CA-1a cells on intact Ubx fibers 
at 48 hours after the initial seeding in the presence of GM6001. 
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Differential cytoskeletal topography between different cell lines and surface dimensions 
  The integrity of the cytoskeleton is a good indicator of healthy cells. Due to the 
limitation of live/dead cell viability assay for the visualization of cytoskeleton, addition 
assay may be required for revealing the cellular structures.  Therefore, we applied 
immunochemistry techniques to reveal the morphology of cytoskeleton of different cell 
lines on Ubx materials, to have a comprehensive visualization of cellular using the α- 
tublin. MCF10A cells showed differential cytoskeletal topography on different surfaces 
at 48 hours after initial seeding. MCF10A cells cultured in tissue culture vessels showed 
expended geometrical arrangement of α-tublin (Figure 4.9A).  However, MCF10A cells 
cultured on Ubx fibers have showed more confined α-tublin structure. In addition, there 
was visible alignment between the α-tublin and the axis of Ubx fibers (Figure 4.9B).   
MCF10AT cells, attached to different surfaces, also showed differences in cytoskeletal 
architecture. For MCF10AT cells attached to Ubx fibers, the α-tubulin aligned with the 
axis of Ubx fibers.  Interestingly, some of the MCF10AT cells showed twisted α-tublin 
along the axis of the Ubx fibers, which could be contributed by microenvironment on the 
surface of Ubx fibers. However, MCF10AT cells on the chamber slide exhibited more 
disperse α-tubulin structures compared to MCF10AT cells on Ubx fibers (Figure 4.9C-
D). 
 
 
 
 
 
 
 98 
 
 
Figure 4.9 Discrepancy in cytoskeletal organization in MCF10A and 
MCF10AT cells cultured on different substrates.  (A) MCF10A cells cultured on 
tissue culture vessels stained for α-tublin (green) and nuclei (blue). (B) MCF10A cells 
cultured on Ubx fibers (blue arrows) stained for α-tublin (green) and nuclei (blue). (C) 
MCF10AT cells cultured on tissue culture vessels stained for α-tublin (green) and 
nuclei (blue). (D) MCF10AT cells cultured on the Ubx fibers (blue arrows) stained 
for α-tublin (green) and nuclei (blue).   
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Figure 4.10 Discrepancy in cytoskeletal organization 
in MCF10CA-1a cells on different substrates. (A) 
MCF10CA-1a cells cultured on tissue culture vessels stained 
for α-tublin (green) and nuclei (blue). (B) MCF10CA-1a 
cells cultured on the Ubx fibers (blue arrows) stained for α-
tublin (green) and nuclei (blue) at 24 hours after the initial 
seeding. (C) MCF10CA-1a cells cultured on the Ubx fibers 
stained for α-tublin (green) and nuclei (blue) at 48 hours 
after the initial seeding. Scale bars equal 10 µm in all panels. 
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Disrupted cytoskeleton in MCF10CA-1a cells after prolonged incubation with Ubx 
fibers  
In contrast to MCF10A and MCF10AT cells, MCF10CA-1a showed more 
dramatic changes of cytoskeleton on different substrate surfaces (Figure 4.10). 
MCF10CA-1a cells cultured on chamber slides showed clearly defined more α-tublin 
topography at 48 hours after the initial seeding (Figure 4.10A).  On the other hand, 
MCF10CA-1a cultured on Ubx fibers showed distinguishable changes of α-tublin 
topography corresponding to the structure of Ubx fibers (Figure 4.10B-C). The 
MCF10CA-1a cells on Ubx fibers had divided nuclei and were less compact than 
MCF10CA-1a cells cultured on tissue culture vessels 48 hours.   
 
Discussion 
In this study, we used the combination of confocal imaging and various assays to 
validate the possibility of using Ubx protein based materials for establishing 3D culture 
for characterizing carcinogenesis. Our results indicated that Ubx materials were 
cytocompatible for various isogenic breast mammary gland cell lines regardless of the 
degree of tumorigenesis. Therefore the anti-tumorigenic sequence in the Ubx protein is 
not active in Ubx materials. Similarly, anti-bacterial peptides linked to silk were active 
in silk monomer but not silk materials [228]. Furthermore, MCF10CA-1a cells attached 
on Ubx materials have shown signs of structural destruction that was not observed for 
MCF10A or MCF10AT cells.  We also observed Ubx materials were destroyed by 
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MCF10CA-1a cells, caused, in part, by MMPs. In addition, there was discrepancy in 
cytoskeletal arrangement for all cell lines on tissue culture flask and Ubx materials.  
The properties of surface substrate often influence cellular response 
[200,202,203]. For instance, the surface topography on the substrate can be influential to 
cellular responses [200,202,203,229]. Cell adhesion in 3D environments is often 
different in focal and fibrillar adhesions characterized on 2D substrates which could 
reflect in the composition cytoskeletal components and morphologies [201,230]. As an 
example, epithelial cells have a larger spreading area on a 2D than on a 3D substrate 
[231]. Besides the cell morphology, cells cultured in 3D substrate show enhanced cell 
biological activities than 2D substrate [200,201,232]. For example, human foreskin 
fibroblasts have faster attachment, migration rate, and proliferation on a 3D substrate 
than a 2D substrate [200]. Up-regulation of transforming growth factor β-1 (TGFβ-1) 
along with other mesenchymal regulatory genes indicating an epithelial and 
mesenchymal transition represented are observed in 3D polymer scaffolds [232]. The 
discrepancy of cytoskeletal structure among different MCF10A cell lines on the bottom 
of chamber slide and 3D Ubx materials indicate that cells from individual MCF10A cell 
lines may have adopted the topographical representation of cell-substrate interface. A 
variety of cells have shown this type of behavior on surface substrate.  For example 
various breast cancer cells can align with the axis of the material scaffolds. H605, MCF 
7, and MDA-MB-231 cells show aligned actins and nucleus with polymer scaffolds 
[232]. 
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The MCF10CA-1a specific Ubx materials destruction in this study could be 
caused by proteolysis. Metastatic cancer cells often express high level of proteases 
during invasion [233-235]. Previous studies have shown MC10CA cell lines have up-
regulated proteases such as MMPs at transcriptional and translational level. MCF10CA-
cl and MCF10CA-1a cell lines have up-regulated MMP-2 and MMP-9 expression which 
contribute to the metastatic state of the cells [191,192].  The preservation of Ubx fiber 
integrity under the presence of broad spectrum MMPs inhibitor indicates the essential 
role of MMPs for MCF10CA-1a cells to secure the topographical location on Ubx fiber, 
which is a common phenomenon for cancer invasion [233,236].  
  In addition to proteolysis, the mechanical force from MCF10CA-1a cells can 
also contribute to the structural destruction of Ubx fibers. Cells apply physical stress on 
substrate, an important factor which influences cell development. Cancer cells are 
especially sensitive to mechanical forces [237,238]. Mechanical force and proteolysis 
are both essential components of metastasis. However, some studies have shown that 
both mechanical forces and proteolysis are required for metastasis in vitro but some have 
ruled out the significance of proteolysis [239-242]. Our proteolytic study indirectly 
indicates the importance of proteolysis in Ubx fibers destruction but we could not rule 
out the role of mechanical force in this event. In addition, it is not clear whether other 
cellular mechanisms involved in cell attachment were affected by the presence of the 
broad spectrum MMPs inhibitor. Since the mechanical force is generated by the 
cytoskeleton elements, the disruption of cytoskeleton proteins under the presence of 
MMPs inhibitor may have direct impacts to the application of mechanical force from 
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MCF10CA-1a cells to Ubx fiber. A comprehensive proteomic profiling for 
cytoskelctome may be helpful to reveal the role of cellular signaling associated with 
focal adhesion [243,244].   
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CHAPTER V 
          CONCLUSIONS AND FUTURE DIRECTIONS 
In this study, we have made several discoveries. First of all, we have discovered 
media sources and preparation methods can cause inconsistency in yeast- based assays. 
By testing different media base from different companies, we have found that media 
component from different sources has strong influence on the results generated by yeast 
one- hybrid and yeast-two hybrid assay. Secondly, we have proved the similarity of 
topological features for Ubx binding proteins. By using bioinformatics and yeast two-
hybrid assay, we discovered that most of Ubx binding proteins can be classified into 
several different shapes and 7 of them are enriched with Ubx partner proteins. 
Particularly, α-α superhelix and DNA-RNA three helical bundle have most of Ubx 
binding proteins under these two folds.  We also showed that each disordered region in 
the Ubx protein has different weights on the Ubx-partner protein interactions and they 
are coordinated during interactions.  For instance, the N-terminal regions and mRNA 
alternatively spliced microexon region in Ubx peptide are critical for Ubx to interact 
with other proteins.  The data from yeast two-hybrid assays using truncated Ubx 
peptides missing the N-terminal regions showed weaker interactions with other binding 
proteins. Besides, Ubx isoforms composed by different combinations of individual 
microexon regions show different degree of interaction strength with binding proteins. 
Third of all, we have explored the possibility of using Ubx protein based materials for 
establishing 3D cancer model. The experimental results showed that Ubx materials are 
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not toxic to three types of mammary gland cells tested in this study including MCF10A, 
MCF10AT, and MCF10CA-1a which has different degrees of tumorigenesis. We also 
observed MCF10CA-1a specific destruction on Ubx materials which can be stopped by 
the presence of broad spectrum MMPs proteases inhibitor.      
For future directions, they can be categorized into three different subgroups due 
to the fundamental differences of my dissertation projects.  
For the media component, we have learned that the nitrogen-based media from 
different sources cause the discrepancy. However, it is important to dissect which 
particular ingredient (s) has/have the most impact on the yeast assays. It is possible to 
apply the mass spectrometry to analyze the chemical components in the media 
formulation from different sources and compare the data with bench experiments.  
For the phenomenon of topological selections observed in Ubx protein-partner 
interactions, it will be the ultimate goal to generate structural data on individual Ubx- 
partner protein binding complexes using structural based techniques, such as nuclear 
magnetic resonance (NMR) or X-ray crystallography. Since intrinsically disordered 
proteins often regulate important biological functions and participate in protein-protein 
interactions, the findings will serve as a great model for understanding other possible 
biophysical features for other intrinsically disordered protein interactions.  
For the further application aspect of Ubx biomaterial project, a comprehensive 
profiling of proteases and cytoskeleton proteins at genomic and proteomic level for cells 
incubated with Ubx protein materials will provide a comprehensive view of the cellular 
responses at molecular level. In addition, this information can be used to pinpoint the 
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most possible proteases contributing to the MCF10CA-1a specific Ubx material 
destruction which will provide valuable information for facilitating the development of 
therapeutic strategy for treating cancer patients.   
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